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Atherosclerosis is considered the underlying cause of cardiovascular 
disease (CVD). Involved in the pathogenesis of atherosclerosis are 
inflammation, endothelial dysfunction, thrombosis and oxidative stress, as 
well as the intrinsic characteristics of the arterial wall. 
Some natural compounds or extracts from certain foods have been 
reported to reverse endothelial dysfunction or have anti-inflammatory 
properties. Cellular models can be used to detect such biological activity. 
The nutrient profiles of plasma, urine, whole blood, erythrocytes and 
platelets may be used to identify specific nutritional biomarkers of dietary 
components. Determining which type of sample is most appropriate for the 
detection of nutritional biomarkers is necessary in order to link specific 
metabolites to food consumption. Specifically, differences in the 
metabolomic profile of matrices such as plasma and/or red blood cells 
(RBC) may provide interesting sources of information that have not been 
fully explored, to date. “Omics” technologies offer a promising route 
towards obtaining scientific evidence from these metabolomic profiles. 
 
HYPOTHESIS AND OBJECTIVES: 
We hypothesize that atherosclerosis-specific biological cell approach, such 
as THP-1 monocytes and human aortic endothelial cells (HAEC), could be 
used successfully to study the mechanism-of-action of food extracts and/or 
bioactive compounds while assessing their effects on inflammation and 
endothelial dysfunction. Further, we hypothesize that two different 
biological samples, RBC and plasma from the same blood extraction, can 
provide complementary metabolomic profile information. 
 
Objectives: 
1.   To standardize experimental methodology for testing the mechanism-
of-action of food extracts (such as polyphenol-rich peanut extract) and 
bioactive compounds (such as alpha-tocopherol; AT) while assessing their 
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effect on inflammation and endothelial dysfunction. The procedures used 
are: 
a) THP-1 monocyte system; a lipopolysaccharide (LPS)-inflammation 
model exposed to peanut extract. Measurements include the 
tumour necrosis factor-alpha (TNF-α) cascade: nuclear factor-κB 
(NF-κB) and mitogen-activated protein kinase (MAPK) family, TNF-
α mRNA expression, TNF-α mRNA stability, TNF-α converting 
enzyme (TACE) activity and total TNF-α protein including intra- and 
extracellular protein (Study 1 ). 
b) TNF-α-stimulated HAEC; an endothelial dysfunction model to study 
the effect of the AT molecule on different cellular adhesion 
molecules (CAMs) such as: intercellular cell adhesion molecule-1 
(ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-
selectin. Measurements were conducted at the mRNA and soluble 
protein level to explore their individual involvements in leukocyte 
adhesion to endothelium (Study 2 ). 
 
2.    To apply and standardize high-throughput metabolomic analytical 
techniques such as nuclear magnetic resonance (NMR) spectroscopy, gas 
chromatography-mass spectrometry (GC-MS) and ultra performance liquid 
chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) to 
characterize the metabolomic profile of human RBC and human plasma 
(Study 3 ). 
 
MATERIALS AND METHODS: 
Testing food extracts, or bioactive compound, in in vitro model 
 Anti-inflammatory properties (Study 1 ): 
THP-1 monocytes were incubated with peanut extract (5, 25, 50 and 100 
µg/mL) consisting of 39% flavonols, 37% flavanols and 24% phenolic acid 
(or BAY 11-7082 (5µM) as experiment control) for 1h and then stimulated 
with LPS (500 ng/mL) for 4h. Cytotoxicity was measured as lactate 
dehydrogenase (LDH) activity release. NF-κB and MAPK family were 
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determined by TransAm kit while TNF-α mRNA levels and its mRNA 
stability by RT-PCR. Intra- and extra-cellular TNF-α protein was measured 
by ELISA, and TACE activity by a fluorimetric assay. 
 Endothelial function improvement (Study 2 ) 
The effects of AT (10-150 µM) and BAY 11-7082 (BAY; 0.1 or 1 µM) on 
CAMs mRNA expression as well as their protein soluble form release 
(sCAMs) were tested in HAEC activated by TNF-α (1 or 10 ng/mL). Also, 
the extent of lymphocyte adhesion to activated HAEC was determined. 
 
Nutritional biomarkers profile derived from plasma and RBC (Study 3)  
Fasting blood was drawn from 10 ostensibly healthy individuals, using 
sodium citrate and lithium heparin as anticoagulants. Both plasma and 
RBCs were separated into aqueous and lipid fractions to be analyzed using 
1D and 2D 1H NMR spectroscopy. Fatty acids were analyzed using GC-
MS. Polyphenols were extracted from plasma and RBC by micro-elution 
solid-phase extraction and analyzed by UPLC-MS/MS.  
 
RESULTS 
Study 1  
Peanut extract inhibited the maximal LPS-induced extra-cellular TNF-α 
protein secretion by 18%, 29% and 47% at 25, 50 and 100 µg/mL, 
respectively (P<0.05). LPS stimulation showed that 85% of TNF-α was 
released into the extracellular medium while 15% remained intracellular. 
Peanut extract did not modify NF-κB but, instead, caused a reduction in c-
Jun transcription factor activity (P<0.05), and decreased TNF-α mRNA 
(albeit non-significantly), while having no effect on mRNA stability and 
TACE activity. 
 
Study 2  
Addition of BAY to HAEC stimulated by TNF-α caused a reduction of 
VCAM-1, E-selectin and ICAM-1 mRNA expression by 30%, 30% and 10%, 
respectively. Further, a reduction in the protein quantity of sVCAM-1 by 
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70%, of sE-selectin by 51% and of sICAM-1 by 25% was observed 
compared to HAEC stimulated by TNF-α (P<0.05). 
AT (50, 75 and 150 µM) decreased VCAM-1 mRNA expression by 30% 
and sVCAM-1 protein by 33% compared to HAEC stimulated by TNF-α 
(P<0.05). 
TNF-α-activated HAEC adhesion to human Jurkat-T-lymphocytes was 
higher compared to non-activated HAEC (P<0.05). BAY (2 and 5 µM) 
reduced this lymphocyte adhesion (P<0.05). 
 
Study 3  
1H NMR demonstrated higher aqueous metabolites such as glucose in 
plasma compared to RBC, while RBC contained higher levels of ADP-ATP, 
creatine and acetone than plasma. Lipoproteins and their subclasses were 
higher in plasma than in RBC. 
The percentages of saturated fatty acids (SFA) 16:0, 17:0, 20:0, 24:0 and 
polyunsaturated fatty acids (PUFA) 22:6 n-3 (docosahexaenoic acid) and 
20:4 n-6 (arachidonic acid) were higher in RBC than in plasma (p<0.05) 
while SFA 14:0, monounsaturated fatty acids (MUFA) 14:1 n-5, 16:1 n-7, 
17:1 n-7 and 18:1 n-9 and PUFA 18:3 n-3, 18:2 n-6, 18:3 n-6 and 20:3 n-6 
were higher in plasma than in RBC (P<0.05). Polyphenols differed in 
plasma from those of RBC. Biomarker concentrations were lower in sodium 
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1. The models, of inflammation using THP-1 monocytes and of endothelial 
dysfunction using HAEC, are effective as biological-cell approaches in the 
investigation of atherosclerosis. The methods are repeatable and 
reproducible in testing the potential beneficial effects of natural and 
manufactured extracts, and/or compounds. 
 
2.   A pre-incubation with polyphenol-rich peanut extract and AT, in the 
cellular models studied, is necessary in order to observe protective effects 
against inflammation and endothelial dysfunction stimuli. 
 
3.   Polyphenol-rich peanut extract exerts an anti-inflammatory effect by 
reducing extracellular TNF-α protein. This peanut extract mechanism-of-
action is via the inhibition of c-Jun transcription factor activity. AT improves 
endothelial function specifically by inhibiting VCAM-1 at the mRNA and the 
protein levels. 
 
4.   BAY is confirmed as an effective control molecule for the cell models 
under study. BAY can reduce TNF-α protein (total, extra- and intracellular) 
and TNF-α mRNA levels by inhibiting c-Jun, MEF2 and NF-κB transcription 
factor activity and TACE activity in THP-1 cells. BAY can also reduce 
sVCAM-1, sE-selectin and sICAM-1 protein as well as their mRNA levels 
and, in the endothelial dysfunction model, the adhesion between activated 
HAECs and Jurkat-T-cells. 
 
5.    The combination of NMR spectroscopy, GC-MS and UPLC-MS/MS 
techniques are efficient in generating metabolomic profiles of several 
specific biomarkers of food intake and metabolites (FA, polyphenol, 
aqueous metabolites and lipoprotein content) in plasma and RBC of human 
subjects. 
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6.  Plasma and RBC are two matrices that add complementary information 
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La arteriosclerosis se considera la causa subyacente de la enfermedad 
cardiovascular (ECV). Involucrado en la patogénesis de la arteriosclerosis 
son la inflamación, la disfunción endotelial, la trombosis y el estrés 
oxidativo, así como, las características intrínsecas de la pared arterial. 
Algunos compuestos naturales o extractos de ciertos alimentos se han 
descrito como revertir la disfunción endotelial o tener propiedades anti-
inflamatorias. Los modelos celulares se pueden utilizar para detectar dicha 
actividad biológica. 
Los perfiles nutricionales de plasma, orina, sangre, glóbulos rojos (RBC), 
plaquetas, etc. se pueden utilizar para realizar la búsqueda de 
biomarcadores nutricionales específicos de componentes de la dieta. 
Determinar qué tipo de muestra es la más apropiada para la detección de 
biomarcadores nutricionales es necesario para poder relacionar 
metabolitos específicos con el consumo de ciertos alimentos. 
Específicamente, diferencias en el perfil metabolómico de matrices como 
plasma y RBC pueden ofrecer una interesante fuente de información no 
ampliamente explorado hasta la fecha. Las tecnologías ómicas ofrecen 
una manera prometedora de contribuir a obtener la evidencia científica de 
estos perfiles metabolómicos. 
 
HIPÓTESIS Y OBJETIVOS: 
Se postula que en la arteriosclerosis, mediante una aproximación celular 
biológica, tales como monocitos humanos THP-1 y células endoteliales de 
aorta humana (HAEC), podrían ser utilizados para estudiar el mecanismo 
de acción de los extractos de alimentos y / o compuestos bioactivos sobre 
su efecto en la inflamación y disfunción endotelial. Por otra parte, se 
postula que dos matrices biológicas (RBC y el plasma) son capaces de 
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1. Normalizar la metodología experimental para testar el mecanismo de 
acción de extractos de alimentos (extracto de cacahuete rico en 
polifenoles) y compuestos bioactivos (alfa-tocoferol; AT) y evaluar su 
efecto sobre la inflamación y disfunción endotelial. Para llevar a cabo dicho 
objetivo realizamos: 
 a) sistema de monocitos THP-1, como un modelo de inflamación 
estimulado con lipopolisacárido (LPS), después de la incubación del 
extracto de cacahuete, para estudiar la cascada del tumor necrosis factor-
alpha (TNF-α): nuclear factor-κB (NF-κB) y la familia mitogen-activated 
protein kinase (MAPK), la expresión de mRNA del TNF-α, la estabilidad del 
mRNA del TNF-α, la actividad de la enzima convertidora del TNF-α (TACE) 
y la proteína total del TNF-α incluyendo la proteína intra- y extracelular 
(Estudio 1 ) del TNF-α. 
 b) HAEC estimuladas con TNF-α, como un modelo de disfunción 
endotelial, para estudiar el efecto de la molécula AT en diferentes 
moléculas de adhesión celular (CAMs), tales como la intercellular cell 
adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-
1) y E-selectina, a nivel de mRNA y proteína y su implicación en la 
adhesión de los leucocitos al endotelio (Estudio 2 ). 
 
2. Aplicar y estandarizar técnicas de alto rendimiento de análisis 
metabolómico como espectroscopía de resonáncia magnética nuclear 
(NMR), cromatografía de gases acoplada a un espectrómetro de masas 
(GC-MS) y cromatografía líquida ultra sensible acoplada a un tándem de 
espectrómetro de masas (UPLC-MS/MS), con el fin de caracterizar el perfil 
metabolómico de los RBC y el plasma humano (Estudio 3 ). 
 
MATERIAL Y MÉTODOS: 
Evaluación de los extractos de alimentos o compuestos bioactivos en 
modelos in vitro: 
 Propiedades anti-inflamatorias (Estudio 1 ): 
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Los monocitos THP-1 se incubaron con el extracto de cacahuete (5, 25, 50 
y 100 µg / mL) o BAY 11-7082 (BAY; 5µM) como control experimento, 
durante 1 h y luego fueron estimulados con LPS (500 ng / mL) durante 4 h. 
La actividad de la liberación de la lactato deshidrogenasa (LDH) fue 
utilizada como indicador de la citotoxicidad. NF-kB y la familia MAPK 
fueron determinados por TransAm kit, los niveles del mRNA del TNF-α y la 
estabilidad del mRNA del TNF-α por RT-PCR, la proteína intra- y 
extracelular del TNF-α por ELISA y la actividad de la TACE mediante un 
ensayo fluorimétrico. 
 Mejora de la función endotelial (Estudio 2 ): 
Se evaluó el efecto del AT (10-150 µM) y BAY (0.1 o 1 µM) sobre la 
expresión de mRNA de las CAMs, así como su liberación en forma de 
proteína soluble (sCAMs) en HAECs estimuladas por TNF-α (1 o 10 ng / 
mL). Además, se determinó el grado de adhesión de linfocitos-T-Jurkat a 
las HAECs estimuladas. 
 
Diferencias entre el perfil metabolómico del plasma y los RBC (Estudio 3 ): 
Se obtuvo sangre en ayunas a partir de 10 individuos aparentemente 
sanos, en tubos con citrato de sodio y heparina de litio como 
anticoagulantes. Tanto el plasma y los RBC se separaron en fracciones 
acuosas y lipídicas y fueron analizados mediante 1D y 2D 1H NMR. Los 
ácidos grasos se analizaron mediante GC-MS. Los polifenoles fueron 
extraídos de plasma y glóbulos rojos mediante micro-elución por extracción 
de fase sólida y se analizaron mediante UPLC-MS/MS. 
 
RESULTADOS 
Estudio 1  
El extracto de cacahuete inhibió la proteína del TNF-α extracelular inducido 
por LPS en un 18%, 29% y 47% a 25, 50 y 100 µg / mL, respectivamente 
(P<0.05). La estimulación con LPS reveló que el 85% de TNF-α fue 
liberado extracelularmente, mientras que el 15% permaneció intracelular. 
El extracto de cacahuete no redujo la actividad de NF-κB, pero sí del factor 
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de transcripción c-Jun (P<0.05), disminuyó el mRNA del TNF-α (aunque no 
significativamente) y no tuvo efecto sobre la estabilidad del mRNA ni sobre 
la actividad de TACE. 
 
Estudio 2  
BAY redujo la expresión de mRNA de VCAM-1, de E-selectina y de ICAM-
1 en un 30%, 30% y 10% respectivamente. Además, se observó una 
reducción de la proteína de sVCAM-1 en un 70%, sE-selectina en un 51% 
y sICAM 1-en un 25% comparado con HAECs estimuladas solamente con 
TNF-α (P<0.05). 
AT (50, 75 y 150 µM) disminuyó la expresión del mRNA de VCAM-1 en un 
30% y de su proteína sVCAM-1 en un 33% en comparación con HAECs 
estimuladas solamente con TNF-α (P<0.05). 
El TNF-α activó, de forma significativa, la adhesión de linfocitos-T-Jurkat a 
HAEC en comparación con HAEC no activadas (P<0.05). BAY (2 y 5 µM) 
redujo esta adhesión de linfocitos a HAECs (P<0.05). 
 
Estudio 3  
1H NMR demostró mayores metabolitos acuosos tales como la glucosa en 
plasma en comparación con RBC, mientras que RBC contenían niveles 
más altos de ADP-ATP, creatina y acetona que el plasma. Los niveles de 
lipoproteínas y sus subclases fueron más altos en plasma que en RBC. 
Los porcentajes de ácidos grasos saturados (SFA) 16:0, 17:0, 20:0, 24:0 y 
ácidos grasos poliinsaturados (PUFA) 22:6 n-3 (ácido docosahexaenoico) 
y 20:4 n-6 (ácido araquidónico ácido) fueron mayores en los RBC que en el 
plasma (P<0.05), mientras que SFA 14:0, ácidos grasos monoinsaturados 
(MUFA) 14:01 n-5, 16:1 n-7, 17:1 n-7 y 18:1 n-9 y PUFA 18:3 n-3, 18:2 n-6, 
18:3 n-6 y 20:3 n-6 eran superiores en el plasma que en RBC (P<0.05). 
Los polifenoles encontrados en plasma difieren de los encontrados en 
RBC. Los biomarcadores encontrados en plasma estaban más diluidos en 
las muestras de citrato de sodio comparadas con las de heparina de litio. 
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1. Los modelos de inflamación en células monocíticas THP-1 y de 
disfunción endotelial en células HAEC utilizados como enfoque biológico 
celular específico de arteriosclerosis son métodos repetibles y 
reproducibles para probar los posibles efectos beneficiosos de los 
extractos naturales y sintéticos y / o compuestos. 
 
2. La pre-incubación con extracto de cacahuete rico en polifenoles y AT, en 
los modelos celulares estudiados, es necesario para poder observar 
efectos protectores contra estímulos como la inflamación y disfunción 
endotelial. 
 
3. El extracto de cacahuete rico en polifenoles ejerce un efecto anti-
inflamatorio, reduciendo el la proteína del TNF-α extracelular. Este 
mecanismo de acción del extracto de cacahuete es a través de la 
inhibición de la actividad del factor de transcripción c-Jun. AT mejora la 
función endotelial específicamente inhibiendo VCAM-1 a nivel de mRNA y 
proteína. 
 
4. Se confirma que BAY es una molécula efectiva como control de los 
modelos celulares estudiados. BAY reduce la proteína del TNF-α (total, 
extra- e intracelular) y el mRNA del TNF-α mediante la inhibición de la 
actividad de los factores de transcripción c-Jun, MEF2 y NF-κB y de la 
actividad de TACE en el modelo de la inflamación. Además, BAY reduce 
las proteína sVCAM-1, sE-selectina y sICAM-1 y su expresión de mRNA, 
así como la adhesión de limfocitos a las células endoteliales en el modelo 
de disfunción endotelial. 
 
5. La combinación de las técnicas espectrometría de NMR, GC-MS y 
UPLC-MS/MS son eficientes para generar perfiles metabolómicos de 
varios biomarcadores específicos de la ingesta de alimentos y sus 
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metabolitos (FA, polifenoles, metabolitos acuosos y el contenido de 
lipoproteínas) en plasma y RBC humanos. 
 
6. Plasma y RBC son dos matrices que añaden información 
complementaria en la evaluación de biomarcadores (metabolitos) de la 
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ADAM-17 - a disintegrin and metalloprotease (TACE) 
ADP – adenosine diphosphate 
ANOVA –  analysis of variance 
AT – alpha-tocopherol 
ATP – adenosine triphosphate 
BAY –  BAY 11-7082 
CAMs –  cell adhesion molecules 
cDNA –  complementary deoxyribonucleic acid 
CE – capillary electrophoresis 
CHD – coronary heart disease 
CM – culture medium 
CV – coefficient of variation 
CVD – cardiovascular disease 
D2O – deuterated water 
DHA – docosahexaenoic acid 
DMSO – dimethyl sulfoxide 
DNA – deoxyribonucleic acid 
DSTE – double-stimulated echo 
EDTA – ethylenediaminetetraacetic acid 
ELISA –  enzyme immunosorbent assay 
EPA – eicosapentaenoic acid 
ERK – extracellular signal-regulated kinase 
ESI – electronspray ionization 
EtOH – ethanol 
FA – fatty acids 
FAME – fatty acid methyl ester 
FBS – fetal bovine serum 
FFQ – food frequency questionnaire 
FID – free induction decay 
FT-IR – Fourier transform infrared 
GAPDH – glyceraldehyde 3-phosphate dehydrogenase 
GC-MS – gas chromatography-mass spectrometry 
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HAEC – human aortic endothelial cells 
HDL – high-density lipoprotein 
HPLC – high-performance liquid chromatography 
HRMAS – high resolution magic angle spinning 
HUVEC – human umbilical vein endothelial cells 
Hz – hertz 
ICAM-1 – intercellular cell adhesion molecule-1 
ICR-FT MS – ion-cyclotron resonance Fourier transform mass 
spectrometry 
IL-6 – interleukin 6 
IL-8 – interleukin 8 
IS – internal standard 
JNK –  c-Jun N-terminal kinase 
LBP –  LPS bearing protein 
LC-MS – liquid chromatography-mass spectrometry 
LDH – lactate dehydrogenase 
LDL –  low-density lipoprotein 
LED – longitudinal eddy-current delay 
LFA-1 – leukocyte function antigen-1 
LPS – lipopolysaccharide 
LSGS – low serum growth supplement 
MALDI –  matrix-assisted laser desorption/ionisation 
MAPK –  mitogen-activated protein kinase 
MCP-1 – monocyte chemoattractant protein-1 
mg –  milligrams 
min –  minutes 
mL -  mililiters 
MMP – matrix metalloproteinase 
mPa – milliPascals 
mRNA –  messenger ribonucleic acid 
MUFA – monounsaturated fatty acids 
NF-κB – nuclear factor-kappa B 
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ng –  nanograms 
NMR – nuclear magnetic resonance spectroscopy 
NOESY – nuclear overhauser effect spectroscopy 
ºC – degree Celsius 
OPLS-DA –  orthogonal partial least squares-discriminant analysis 
PBS – phosphate buffered saline 
PC – principal component 
PCA – principal component analysis 
PCR – polymerase chain reaction 
PLS-DA –  partial least squares-discriminant analysis 
PMA – phorbol 12-myristate 13-acetate 
ppm –  parts per million 
PSGL-1 – P-selectin glycoprotein ligand-1 
PTM – post-translational modifications 
PUFA – polyunsaturated fatty acids 
RBC – red blood cells 
RF – radiofrequency  
RFU – relative fluorescence units 
RIPA – radio-immunoprecipitation assay 
RNA – ribonucleic acid 
ROS – reactive oxygen species 
RSD – relative standard deviation 
rt RT-PCR –  real time reverse transcription polymerase chain reaction 
RT-PCR – reverse transcription polymerase chain reaction 
sCAMs –  soluble cell adhesion molecules 
SD – standard deviation 
sec –  seconds 
SEM – standard error of the mean 
sE-selectin – soluble E-selectin 
SFA – saturated fatty acids 
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SPSS – statistical package for the social sciences 
SRM – selected reaction monitoring mode 
sVCAM-1 –  soluble vascular cell adhesion molecule1 
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TF – tissue factor 
THP-1 – monocytic cells 
TLR4 – toll-like receptor-4 
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TNF-α – tumour necrosis factor-alpha 
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tandem mass spectrometry 
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Chapter 1.  Atherosclerosis  
Atherosclerosis is considered the underlying cause of cardiovascular 
disease (CVD) (Hansson GK, 2005). It is a progressive, chronic, 
inflammatory disease characterized by the accumulation of lipids and 
fibrous elements within the artery wall. It constitutes the single most 
important contributor to the growing burden of CVD (Libby P et al., 2002). 
Atherosclerosis is characterized by the formation of lesions in the large and 
medium sized arteries, often at sites of disturbed blood flow. The World 
Health Organization (WHO) has published a serial of key facts related to 
the importance of CVD facts in the world (Organization WWHFWS, 2011): 
 
1. CVD is the number one cause of death globally: more people die 
annually from CVD than from any other cause. 
2. An estimated 17.3 million of people died from CVD in 2008, 
representing 30% of all global deaths. An estimated 7.3 million, out 
of these deaths, were due to coronary heart disease and 6.2 million 
of them were due to stroke. 
3. Low- and middle-income countries are disproportionately affected: 
over 80% of CVD deaths take place in low- and middle-income 
countries and occur almost equally in men and women. 
4. By 2030, it is calculated that almost 23.6 million of people will die 
from CVD, mainly from heart disease and stroke. These causes 
remain as the leading causes of death in the world. 
 
1.1 Pathogenesis of atherosclerosis  
The first stage in the development of atherosclerotic plaques is the 
recruitment of monocytes at arterial lumen. The recruitment of circulating 
monocytes occurs via a tightly regulated multi-stage process mediated by 
combination of cell surface adhesion molecules (Libby P et al., 2011) 
(Figure 1). 
Activated endothelial cells, at sites of incipient atherosclerosis, initially, 
express E- and P-selectin (Rader DJ and Daugherty A, 2008). They 
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Figure 1. Early stages of atherosclerotis . Endothelial cell activation can be initiated by 
inflammation, which leads to an increase in the expression of leukocyte adhesion molecules (e.g., 
E-selectin, VCAM-1 and ICAM-1). Migration of monocytes to the vessel wall is largely controlled by 
VCAM-1. Adherent monocytes pass between intact endothelial cells to penetrate into the intima, the 
innermost layer of the arterial wall. Within the intima, monocytes transform into macrophages, 
which, throuth scavenger receptors, bind oxidized LDL, thereby leading to the formation of foam 
cells. The progressive accumulation of lipids and foam cells leads to the formation of fatty streaks. 
Foam cells produce ROS and proinflammatory cytokines. Foam cells produce ROS and 
proinflammatory cytokines (TNF-α, IL-1β, IL-6) that, in turn, activate the expression of adhesion 
molecules, facilitating further recruitment of T cells and macrophages. The activated mononuclear 
phagocyte has a key role in the thrombotic complications of atherosclerosis of atherosclerosis by 
producing MMPs, which can degrade extracellular matrix that lends strength to the fibrous cap of the 
plaque. Source: (Libby P et al., 2002) 
mediate the tethering and rolling of circulating monocytes, which, at the 
same time, express L-selectin. P-selectin binds to P-selectin glycoprotein 
ligand-1 (PSGL-1) and other glycosylated ligands on monocytes (Elstad 
MR et al., 1995; Weyrich AS et al., 1995). There is data suggesting that E-
selectin is inducible expressed at sites of atherosclerosis. However, 
functional data, in relevant models that would directly support a role for this 
molecule, are lacking. Under normal blood flow, selectin-mediated 
interactions are not sufficient to arrest rolling leukocytes (Burnier L et al., 
2009). Selectins (P, E and L) not only allow the capturing and rolling of 
leukocytes on the endothelium, but they also signal through PSGL-1 to 
activate integrins and induce monocyte activation (Weyrich AS et al., 
1995). Integrins are heterodimeric cell surface receptors and support both 
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rolling and adhesion of leukocytes. Upon activation, integrins undergo a 
series of conformational changes that result in increased binding affinity for 
their respective ligands, such as vascular cell adhesion molecule-1 (VCAM-
1). That binding affinity creates a firm adhesion state to endothelium. 
VCAM-1 is a member of the immunoglobulin-like superfamily of adhesion 
molecules and, although not routinely expressed under physiological 
conditions, is induced on the cytokine-stimulated endothelium by tumour 
necrosis factor-alpha (TNF-α), a cytokine present in the initiation and 
progression of atherosclerosis (Kleemann R et al., 2008). 
Once adhered and contacted with the activated endothelial layer, 
monocytes migrate into the tunica intima. In this process, various 
chemokines participate and interact, for example monocyte 
chemoattractant protein-1 (MCP-1) (Mestas J and Ley K, 2008). 
Once resident in the intima, monocytes acquire characteristics of the tissue 
macrophage. The macrophage expresses scavenger receptors that bind 
internalized lipoprotein particles, previously modified by oxidation or 
glycation. These processes give rise to arterial foam cells, a hallmark of the 
arterial lesion. This lesion is the result of accumulation of lipid droplets 
within the cytoplasm (Libby P et al., 2009). Foam cells secrete pro-
inflammatory cytokines, which amplify the local inflammatory response in 
the lesion, and reactive oxygen species (ROS). The activated macrophage 
foam cells (Figure 1) have a key role in the thrombotic complications of 
atherosclerosis because they produce matrix metalloproteinases (MMPs) 
(Rajavashisth TB et al., 1999). MMPs degrade extracellular matrix leading 
to the accumulation of dead cells that strengthen plaque’s fibrous cap. If 
the plaque ruptures, the blood flow contacts the potent pro-coagulant 
protein tissue factor (TF). This is another macrophage product, which could 
lead to thrombosis. (Blankenberg S et al., 2003). Macrophages congregate 
in a central core in the typical atherosclerotic plaque. Macrophages can die 
in this location (e.g. by apoptosis) hence producing the so-called ‘lipid or 
necrotic core’ of the atherosclerotic lesion (Ross R, 1999b; Libby P et al., 
2002; Libby P et al., 2011). 
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This advanced obstructive lesion leads to the final stages of 
atherosclerosis, which includes calcification and probably plaque rupture 
(Figure 2). This physical disruption not always results in plaq ue rupture. 
Physical disruption of plaques may trigger thrombosis and thus promote 
sudden expansion of atheromatous lesions (Stary HC et al., 1995; Davis 
PA et al., 2006). 
 
Figure 2. Atherosclerotic lesion development.  Atherosclerosis occurs at sites in the arterial tree 
where laminar flow is disrupted. (a) The normal artery contains three layers. The inner layer, the tunica 
intima, is lined by a monolayer of endothelial cells that is in contact with blood overlying a basement 
membrane. In contrast to many animal species used for atherosclerosis experiments, the human intima 
contains resident smooth muscle cells (SMCs). (b) The initial steps of atherosclerosis include adhesion 
of blood leukocytes to the activated endothelial monolayer, directed migration of the bound leukocytes 
into the intima, maturation of monocytes (the most numerous of the leukocytes recruited) into 
macrophages, and their uptake of lipid, yielding foam cells. (c) Lesion progression involves the migration 
of SMCs from the media to the intima. Plaque macrophages and SMCs can die in advancing lesions, 
some by apoptosis. Extracellular lipid derived from dead and dying cells can accumulate in the central 
region of a plaque, often denoted the lipid or necrotic core. Advancing plaques also contain cholesterol 
crystals and microvessels. (d) Thrombosis, the ultimate complication of atherosclerosis, often 
complicates a physical disruption of the atherosclerotic plaque. Shown is a fracture of the plaque’s 
fibrous cap, which has enabled blood coagulation components to come into contact with tissue factors in 
the plaque’s interior, triggering the thrombus that extends into the vessel lumen, where it can impede 
blood flow. Source: (Libby P et al., 2011) 
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Three types of physical disruption may occur (Virmani R et al., 2002a; 
Virmani R et al., 2002b): 
 
1. Superficial erosion  or microscopic areas of desquamation of 
endothelial cells that form the monolayer covering the intima. 
Although common and most often asymptomatic, such superficial 
erosion may account for approximately 25% of fatal coronary 
thromboses. 
2. Disruption of the microvessels. Atheromatous lesions develop 
microvascular channels because of neo-angiogenesis. Intra-plaque 
deposition of fibrin, fibrin-split products, and haemosiderin provide 
evidence of intra-plaque haemorrhage. In this way, a silent 
microvascular haemorrhage, within the atherosclerotic intima, could 
give rise to a growth spurt in the evolution of the plaque. 
3. Plaque rupture. The plaque fibrous cap encompasses 
inflammation events and usually serves to attract the thrombogenic 
lipid-rich core of the atheroma from the bloodstream, which 
contains circulating coagulation proteins. Rupture of the fibrous cap 
allows the coagulation factors to contact with TF, the main pro-
thrombotic stimulus found in the lesion’s lipid core. The ruptured 
fibrous cap causes approximately 75% of acute myocardial 
infarctions. 
 
These examples illustrate the inextricable links between thrombosis and 
lesion progression. Usually, below the clinical threshold, evolution of the 
lesion occurs silently, leading to transition from the fatty to the fibrous 
atherosclerotic plaque (Libby P et al., 2002). 
 
1.2  Mechanisms involved in atherosclerosis  
Endothelial dysfunction and inflammation, often induced by 
hypercholesterolemia or other cardiovascular risk factors, are the initial 
stages of atherosclerosis and play a key role on its development. In the 
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Figure 3.  Leukocyte recruitment in atherosclerosis inflammation.  Non-specific pro-inflammatory 
factors (TNF-alpha, interleukin-1, -6 and -18) and endothelial activation factors (soluble VCAM-1, 
ICAM-1 and CD40L) are some of the inflammatory markers correlated with the activation of the 
atherosclerotic cascade process. Source: Beat Imhof from Abcam ® 
present work, we focus on these early stages of atherosclerosis; 
inflammation and endothelial dysfunction. 
 
1.2.1 Inflammation 
Up to date, the relationship between inflammation and atherogenesis has 
been studied mainly by focusing on prognostic influence of inflammatory 
biomarkers, with respect to conventional risk factors, and less by assessing 
the possible pathogenic effect of atherosclerotic plaque progression. 
The interactions between monocytes and endothelial cells play a key role in 
the development of vascular lesion, inflammation, and atherosclerosis. 
Inflammatory and innate immune mechanisms, both employing monocytes, 
innate receptors, innate cytokines, and chemokines are suggested to be 
involved in atherogenesis (Loppnow H et al., 2008). Among the 
inflammatory mechanisms, the cytokines are central players (Figure 3). 
 
Innate cytokines, such as IL-1 or TNF-α, may activate the cells. Cytokines 
potentially activate multiple mechanisms relevant to maintenance or 
impairment of homeostasis within the vessel wall. Vascular cells, but not 
least smooth muscle cells, can actively contribute to the inflammatory 
cytokine-dependent network in the blood vessel wall (Balanescu S et al., 
2010). 
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Figure 4. Endothelial dysfunction . E-selectin-mediated slow rolling, and indirectly by signals 
transmitted through adjacent receptors. Leukocyte arrest is mediated by firm binding to adhesion 
molecules, including E-selectin, ICAM-1 and VCAM-1. Adapted figure from: (Navarro-Gonzalez JF et 
al., 2011) 
1.2.2 Endothelial dysfunction 
When inflammation process has initiated, endothelial dysfunction develops 
rapidly. The first changes preceding the formation of atherosclerotic lesions 
take place in the endothelium. These changes include the up-regulation of 
leukocyte adhesion molecules, by L-selectin, integrins, and platelet–
endothelial-cell adhesion molecule-1, and the up-regulation of endothelial 
adhesion molecules, which include E-selectin, P-selectin, intercellular 
adhesion molecule-1 (ICAM-1), and VCAM-1. Endothelial permeability to 
lipoproteins and other plasma constituents increases. This permeability is 
mediated by nitric oxide, prostacyclin, platelet-derived growth factor, 
angiotensin II, and endothelin. Thanks to this permeability, leukocytes can 
migrate to the artery wall. The migration is mediated by oxidized low-
density lipoprotein, monocyte chemotactic protein-1, interleukin-8, platelet-
derived growth factor, macrophage colony-stimulating factor, and 
osteopontin (Ross R, 1999a) (Figure 4). 
 
 
1.3  Atherosclerosis risk factors  
The human advanced age predisposes to endothelial dysfunction and 
subsequent development of atherosclerosis. However, the presence of 
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several risk factors, for example elevated blood cholesterol, does not 
always accompanies the development of atherosclerosis. In the contrary, 
suffering from endothelial dysfunction always does (Catapano AL et al., 
2011). 
The exact cause of atherosclerosis remains unknown and certain traits, 
conditions, exposures or habits may raise an individual’s probability of 
developing it. These conditions are known as risk factors and a person’s 
likehood of developing atherosclerosis increases with the number of risk 
factors he or she accumulates. Most of these risk factors can be modifiable 
and thus controlled such as diet, physical activity, alcohol and tobacco 
consumption. Others, called non-modifiable, cannot be controlled like age, 
sex and genetic predisposition (family history of premature coronary heart 
disease (CHD)/genotype) (Ordovas JM, 2006). 
Atherosclerosis risk factors can also be intermediate. These include a) high 
levels of total blood cholesterol, b) high levels of blood low-density 
lipoprotein cholesterol (LDL), c) low levels of blood high-density lipoprotein 
cholesterol (HDL), d) hypertension (high blood pressure), e) diabetes 
mellitus/glucose intolerance and f) obesity/overweight. Moreover, exist 
atherosclerosis emerging risk factors such as lipoptrotein (a), 
homocysteine, prothrombotic factors, proinflammatory factors and impaired 
fasting glucose levels (Longo DL, 2011). The combination of the above risk 
factors can lead to the development of CHD, stroke peripheral vascular 
disease and CVD in general (Catapano AL et al., 2011). 
Multiple biochemical risk factors for atherosclerosis and CVD include 
disordered lipid profiles, autoimmunity, infection, high levels of 
homocysteine, asymmetrical dimethylarginine, C-reactive protein, genetic 
predisposition and various metabolic diseases (Dominiczak MH, 2001; 
Grant PJ, 2003; Maas R and Boger RH, 2003). Many risk factors act in a 
coordinated or synergistic way participating in one or more inflammatory 
pathways. Markers of these risk factors can be detected on three cell types 
where they coordinate their action to influence cardiovascular dynamics, 
function, and structure (Osiecki H, 2004). 
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These cell types are: 
 Immune cells : monocytes / macrophages and T lymphocytes, 
situated in the circulating blood, which defend the endothelium and 
smooth muscle cells (SMC) from chemical and biological insult. 
 Endothelial cells:  situated between circulating blood in the lumen 
and the rest of the vessel wall. They control the intra- and trans-
cellular flow of nutrients, hormones, and immune cells, and 
regulate vascular tone and blood flow. 
 SMC or vascular smooth muscle cells (VSMC):  found at the 
vessel wall, maintain vascular tone and structure. 
 
Activation of the molecular mechanisms, involved in the recruitment of 
monocytes by endothelial cells, leads to the development of early 
atherosclerosis stages. 
Screening for early stages of atherosclerosis, at which intervention is most 
effective, proves to be better than just following disease evolution and aid 
in the titration of therapy, by detecting the presence of vulnerable plaque 
that requires aggressive intervention (Cai JM et al., 2002). Screening 
molecular biomarkers should be specific for each atherosclerosis early 
stage because its management may vary at different stages of the disease. 
Thus, detection of biomarkers can be useful for the screening of patients 
with cardiac risk factors. Biochemical risk biomarkers, in particular, play a 
crucial role in all stages of atherosclerosis process, and entail a great 
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Chapter 2.  Biomarkers  
A biomarker or biological marker is a characteristic that is objectively 
measured and evaluated as an indicator of normal biological processes, 
pathogenic processes, or pharmacologic responses to a therapeutic 
(Vasan RS, 2006) or nutritional (Puiggros F et al., 2011) intervention. 
 
2.1  Classification of biomarkers  
Biomarkers reflect the entire spectrum of a disease from the earliest 
manifestations to the terminal stages. The current literature contains 
numerous reports on the relationship between various biomarkers of 
atherosclerosis early stages and prospective cardiovascular risk, in 
apparently healthy individuals (van Kimmenade RR and Januzzi JL, Jr., 
2012). 
As mentioned before, a risk factor is associated with a disease when it 
belongs to the causal pathway leading to the disease. Related to that, a 
risk biomarker is associated with the disease (statistically) but not always 
causally linked to it. Risk biomarker may be a measure of the disease 
process itself (Vasan RS, 2006). 
To evaluate the exceptional value of a new biomarker, investigators must 
demonstrate the elevated risk of a disease outcome associated with higher 
levels of the new biomarker after adjustment for other established risk 
factors (Kattan MW, 2003). Very strong associations between biomarkers 
and a certain disease are required for a given biomarker to have good 
discrimination properties (Pepe MS et al., 2004; Revkin JH et al., 2007). 
Biomarkers are directly or indirectly linked to the stages of the causal 
pathway of a disease and thus strongly related to it (Mayeux R, 2004). 
Level or type of exposure to an external factor, response to exposures 
genetic susceptibility, symptoms of subclinical or clinical disease, and 
indicators of therapy response are some of the characteristics that a 
biomarker should also have. An easy way to think of biomarker is as 
indicators of a disease trait, disease state, or disease advanced stages 
(Vasan RS, 2006). 
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Figure 5. Disease pathway and impact of biomarkers . Biomarkers can act at different levels of 
disease stages and according to that they can be classified as: antecedent biomarkers , identifying 
the risk of developing an illness; screening biomarkers , screening for subclinical disease; 
diagnostic biomarkers , recognizing the disease per se; staging biomarkers , categorizing disease 
severity; or prognostic biomarkers , predicting future disease course, including recurrence and 
response to therapy, and monitoring efficacy of therapy. Adapted figure from (Mayeux R, 2004) 
As we can see in Figure 5 , Mayeux R has classified biomarkers as: 
1. Antecedent biomarkers , those which are able to predict the 
developing of a disease. 
2. Screening biomarkers , those which can detect the subclinical 
stages of a disease. 
3. Diagnostic biomarkers , those which are representative of a 
specific disease. 
4. Staging biomarkers, t hose which determine the degree of a 
disease. 
5. Prognostic biomarkers , those which give some information about 

























The clinical use of a biomarker for a disease risk prediction and/or 
prevention depends on its feasibility, ease, cost, and reproducibility of the 
measurement, and the ability to add value to the predictability of existing 
biomarkers (Libby P et al., 2009). 
It is very difficult to identify biomarkers of exposures to any agent (drug, 
environmental factor, food, etc.) that are stable over long periods, as 
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required in biomarker prospective studies. Timing, persistence, dose, and 
storage site must all be evaluated for the evaluation of a biomarker. 
Numerous studies, addressing single food components or nutrients 
biomarkers, have been conducted in vitro but few, if any, have been 
translated in vivo into free-living population studies (Puiggros F et al., 
2011). 
 
2.2  Nutritional biomarkers  
Another type of increasingly interesting class of biomarkers is the 
biomarkers of dietary intake. These are called nutritional biomarkers and 
they play a major underlying role in the causation of the global burden of 
chronic diseases (Heinzmann SS et al., 2010); for example, a healthy diet 
rich in fruit and vegetables is associated with lower rates of some diseases 
such as CVDs, and its related risk factors (Roodenburg AJ et al., 2000). 
Diet questionnaires, such as 24-h recalls (24 hR), weighted food diaries 
and food frequency questionnaires (FFQs), offer an historical account of 
the exposure (diet), but direct measurement of food consumption can 
provide more accurate information regarding the kind of ingestion (Puiggros 
F et al., 2011). 
Moreover, foods, like fruit, vegetables, red wine and coffee, are usually 
complex mixtures of a large amount of molecules, nutrients and non-
nutrients, present either naturally or accidentally. All of them affect the 
tissues of the organisms producing chemical changes on the anabolism 
and catabolism known as metabolic effects. 
The metabolome includes not only the above-mentioned molecules but 
also hundreds of thousands of food compounds that do not have metabolic 
effects but they are rather used to convert a food into a gastronomic delight 
(Heinzmann SS et al., 2010). Thus, it is of great importance the use of a 
specific biomarker able to provide valuable and accurate information of 
particular foods consumption. 
Nutrient profiles derived from biologic samples such as plasma, urine, 
blood, erythrocytes, platelets and hair samples may be used to search for 
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biomarkers of specific dietary components consumption (de Roos B et al., 
2008). The challenge is to choose the appropriate sample-substrate for the 
detection of a specific nutrient compound. Information reflecting recent or 
sustained consumption depends on the tested biological sample. Hence, a 
nutritional biomarker can reflect either a recent intake (testing the 
compliance of short-term studies e.g. postprandial) or the consumption 
over a longer period (e.g. epidemiological studies or long-term 
interventions). 
 
2.2.1 Promising applications of nutritional biomarkers  
In order to identify nutritional biomarkers and establish their relationship to 
food consumption, it is useful to create a strategy that combines 
metabolome-wide association. This strategy includes evaluating untargeted 
metabolic profiles in nutritional intervention studies. The validation of these 
profiles in free-living populations helps to identify nutritional biomarkers of 
food intake. The use of a nutrimetabolomics (Savage AK et al., 2009) 
approach to identify and verify a new nutritional biomarker may facilitate the 
evaluation of a disease risk factor. Moreover, nutrimetabolomics could 
facilitate individual diets effect aiming at a healthier eating, lifestyle and 
longevity. The development of robust nutritional biomarkers may reduce 
disease risk by better characterizing the metabolic phenotype, at the 
individual level, after the adherence to a specific diet (Heinzmann SS et al., 
2010). 
The growth of molecular biology techniques has been largely and rapidly 
expanded during the last decades. The use of those advanced methods will 
lead to the detection of new biomarkers (Puiggros F et al., 2011). 
Nutritional and risk biomarkers will provide a dynamic and powerful 
approach for the understanding of CVD. Moreover, they will have 
significant applications in analytic epidemiology, clinical trials and 
prevention, diagnosis, and management of the disease. 
At this point, it is important to introduce the relative new concept of 
“foodomics ”. Foodomics is defined as the discipline that studies the Food 
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and Nutrition areas through the application of “omics” technologies to 
characterise and demonstrate the beneficial effects of food ingredients on 
human health (Cifuentes A, 2009). Today, foodomics analysis is 
considered a well-established systems approach to characterise the global 
metabolic profile of low molecular mass compounds (<1,500 Da) in 
biofluids (e.g., plasma, serum, urine). These complex biochemical 
fingerprints of hundreds, or even thousands, of metabolites reflect the 
overall metabolic status of an individual (Puiggros F et al., 2011; Herrero M 
et al., 2012). 
Advanced analytical methodologies, ‘‘omics’’ approaches and 
bioinformatics tools—together with in vitro, in vivo, and/or clinical assays— 
are applied to investigate topics in food science and nutrition field that few 
years ago were considered unfeasible (Herrero M et al., 2012). 
Nuclear magnetic resonance (NMR) spectroscopy or mass spectrometry 
(MS) are used as high-resolution spectral analyses tools to determine 
metabolic signatures from biological samples (Nicholson JK et al., 1999). 
These techniques help us obtain complex profiles of a wide range of 
metabolite classes (Lindon JC and Nicholson JK, 2008). The metabolic 
signatures fully characterize the metabolism and contribute to our 
understanding of cell biology, physiology and medicine (Heinzmann SS et 
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Chapter 3.  Metabolomics  
 
3.1 Overview  
On of the most important tasks in the field of molecular biology is to 
understand the complex molecular interactions of biological systems. This 
task is becoming one of the most rapidly growing areas over the last 
decade. ‘Omics’ technologies, like functional genomics tools, enable us to 
bridge the gap between genotype and phenotype at system level. 
Transcriptomics and proteomics allow a comprehensive analysis of the 
expression changes of genes and proteins, respectively, in a biological 
system. The metabolome represents the collection of all metabolites in a 
biological cell, tissue, organ or organism, which are the end products of 
cellular processes (Schmidt CW, 2004).  
In the first place, metabonomics was defined as the quantitative 
measurement of the dynamic multiparametric metabolic response of living 
systems to pathophysiological stimuli or genetic modification (Nicholson JK 
et al., 1999). Nowadays, metabolomics is defined as the systematic study 
of metabolite profiles of small molecules-unique chemical fingerprints 
resulting after specific cellular processes (Schmidt CW, 2004).  
Metabolomics, a relatively new discipline, completes the ‘omic’ hierarchy by 
quantifying and identifying all the metabolites existing in or produced by an 
organism (Figure 6) (Tweeddale H  et al., 1998; Ellis DI et al., 2007). 
Up to now, metabolomics itself lacks a direct connection to the genome, as 
happens with transcriptomics and proteomics. Metabolomics is the final 
stage in the analysis of the genetic information flow, which reflects more 
closely the phenotypic changes in a cell, tissue or organism upon a genetic 
modification or physiological perturbation. The present estimate of the 
human metabolome is over 7,900 metabolites (Wishart DS et al., 2009).  
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What appears to be happening





Although the size of metabolome is considerably smaller than the size of 
genome, challenges remain in detecting and identifying all the metabolites 
within the body. A metabolite is defined as a molecule with less than 1 kDa 
size (Samuelsson LM and Larsson DG, 2008). However, there are 
exceptions depending on the sample and detection method. For example, 
macromolecules such as lipoproteins and albumin are reliably detected in 
NMR-based metabolomics studies of blood plasma and could also serve as 
metabolites (Nicholson JK et al., 1995). These small molecules vary 
significantly in terms of their molecular weights, concentrations, polarity, 
solubility and volatility. Unlike genes, mRNAs and proteins, which are all 
species-specific, metabolites are universal and metabolic pathways are 
highly conserved among species. This enable us to safely transfer our 
metabolic changes knowledge from model systems of human pathology to 
the human organism (Oliver S, 2000).  
In a specific biological system, metabolites may rapidly suffer various 
modifications, in response to environmental stimuli. Studies show that even 
minor changes of enzymatic activity may result in great changes in 
metabolite concentrations despite the little changes in metabolic flux (van 
der Greef J et al., 2004). This characteristic enables metabolomics to 
function as a more sensitive tool to discover novel biomarkers and to gain a 
better understanding of the disease process. Raamsdonk LM et al. 
demonstrated that metabolomics can be used as a valuable tool to identify 
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silent mutations in yeast, which shows no obvious phenotype despite the 
deletion of genes (Raamsdonk LM et al., 2001). An array of different 
analytical platforms is employed in metabolomics studies to maximize the 
coverage of metabolites that can be detected within a sample. 
Metabolomics can offer further advances in nutritional biomarker discovery 
and pathway identification due to their cheaper per sample basis, when 
compared with transcriptomics and proteomics approaches (Griffin JL, 
2006; Rhee EP and Gerszten RE, 2012). An important part in the study of 
nutritional biomarkers is the developments of analytic techniques that allow 
us to determine specific components or molecules after food consumption. 
These techniques should be robust, reproducible, rapid and low cost. 
 
3.2 Application of metabolomics in atherosclerosis 
research  
CVD provides an exciting area that could be explored by metabolomics. 
Apart from the individual genetic predisposition of the disease, the majority 
of the CVD cases are closely associated to environmental factors. 
Diabetes, obesity and a sedentary lifestyle greatly contribute to the 
development of CVD by disturbing the homeostasis (balance of internal 
environment) of system metabolism in the human body. Thus, the 
importance of measuring metabolic changes at multiple levels, in the study 
of atherosclerosis, has become increasingly necessary to better 
understand the phenotype of the disease (Figure 7 ) (Jones GL et al., 
2005). For example, Chen X et al. has recently applied gas 
chromatography-mass spectrometry (GC-MS)-based metabolomics 
analysis to reveal novel atherosclerosis biomarkers (Chen X et al., 2010). 
Analysis of plasma samples from study patients showed that 
atherosclerosis alters fatty acid metabolism, especially that of palmitate, 
suggesting that the development of atherosclerosis can induce 
overproduction of palmitate (Chen X et al., 2010). 
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Figure 7. The pathophysiology of atherosclerosis involves interacting systems at multiple 
levels.  A) Genetic and environmental factors; B) Multiple organs and organ systems are involved in the 
disease process; C) Risk factors that are influenced by genetic and environmental inputs and that 
involve multiple organ systems contribute to the development and progression of atherosclerosis; D) 
Atherosclerosis progresses through several stages, each of which involves the interaction of multiple 
cell types and molecular processes. Source: (Ramsey SA et al., 2010) 
 
Thus, palmitate metabolic profile changes could be used as a potential 
biomarker to assist the clinical diagnosis of such disease.  
The nature of collecting plasma or urine samples from patients facilitates 
the success of CVD biomarker discovery. However, plasma and urine 
metabolic profiling may not be the best reporter of CVD. These profiles only 
represent the sum of all the metabolic changes occurring in the human 
body, and also suffer from inter-individual variability produced by diet and 
drug effects. Thus, a lot of the cardiovascular studies focus on cellular and 
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animal models of the disease, and study the tissues of interest to gain a 
more detailed picture of the disease process (Doring Y et al., 2012). 
 
3.3 Analytical laboratory techniques  
From an analytical point of view, metabolomic methodologies are a highly 
valuable tool that provides an adequate evaluation of the low molecular 
weight food metabolites present in biological samples (Rull A et al., 2009; 
Vinaixa M et al., 2010). The methodologies used in metabolomics 
experiments may use different type of biological samples. Fluids secreted 
or excreted from a living organism (biofluids) reflect a concrete biochemical 
status because their composition is a direct consequence of a cell function, 
an organ dysfunction or a disease. Dietary, diurnal, and hormonal 
variations may also influence biofluid compositions. Thus, it is important to 
distinguish these effects in order to conclude accurate biochemical 
information from biofluid analysis (Lindon JC et al., 2000). 
Some of the most common biofluids used in metabolomic analysis include 
but not limited to urine, blood plasma, blood serum, whole blood, bile, 
gastric juice, seminal fluid, etc. A specific analytical approach is required to 
analyse a biofluid, a tissue extract or an intact tissue. 
Metabolomics methodologies are divided into two distinct groups: a) 
untargeted metabolomics, a detailed comprehensive analysis of all the 
measurable analytes in a sample; and b) targeted metabolomics, the 
measurement of previously known biochemically annotated metabolites 
(Roberts LD et al., 2012). Buscher JM has classified metabolomic 
technologies into two methods: 
 Separation methods:  gas chromatography (GC), high-
performance liquid chromatography (HPLC) and capillary 
electrophoresis (CE). 
 Detection methods:  mass spectrometry (MS) and NMR 
spectroscopy. 
To identify and to quantify metabolites it is necessary to combine 
separation methods (GC, HPLC and CE) with a MS detection method. 
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NMR spectroscopy is the only detection method which does not based on 
separation of the analytes, thus the sample can be recovered for further 
analyses (Buscher JM et al., 2009). 
The major technologies that are used in metabolomics include: a) 1H NMR 
spectroscopy, b) gas chromatography–mass spectrometry (GC–MS) and c) 
liquid chromatography–mass spectrometry (LC–MS). Other techniques are 
also used and include Fourier transform infrared (FT-IR) spectroscopy, 
HPLC or CE in conjunction with diode or Coulometric arrays and ion-
cyclotron resonance Fourier transform (ICR-FT)-MS (Griffin JL and 
Shockcor JP, 2004; Puiggros F et al., 2011). In this present work, we use 
NMR, GC-MS and LC-MS techniques to study the biological samples of 
interest. 
 
3.3.1 Nuclear magnetic resonance spectroscopy 
NMR spectroscopy is a non-invasive analytical chemistry technique based 
on the magnetic property of a molecules-atom’s nucleus (Weber H and 
Brecker L, 2000). NMR spectroscopy has been widely used in 
metabolomics. It is a robust, high-throughput and non-destructive approach 
and its advantage is the requirement of minimal sample preparations 
(Lindon JC et al., 2003). 
NMR relies on the study of a magnetic nucleus by aligning it with a very 
powerful external magnetic field and disturbing the alignment using an 
electromagnetic field (Figure 8). NMR studies the nucleus response to the 
field after this disturbance. Different atoms, within a molecule, resonate at 
different frequencies at a given field strength. The observation of a 
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Figure 8. The basic arrangement of an NMR spectrometer . The sample is positioned in a very 
strong magnetic field. The super conducting magnet is cooled by liquid nitrogen and helium. Pulses of 
radio waves are sent into the sample which emits a radio wave response. This response is analyzed in 
a computer, resulting an NMR spectrum. The pulse is repeated as many times as necessary to allow 
the signals to be identified from the background noise. Each group of signals corresponds to protons in 
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Figure 9 . Energy levels for a nucleus with spin . In the absence of a magnetic field, these are 
randomly oriented but when a field is applied they line up parallel to the applied field, either spin aligned 
or spin opposed. 
The usually applied isotopes in NMR are hydrogen-1 (1H) and carbon-13 
(13C). These isotopes are non-radioactive. Certain isotopes of many other 
nuclei elements may also be used. Subatomic particles (electrons, protons 
and neutrons) can be simulated as spinning on their axes. In some atoms 
(such as 1H and 13C) the nucleus possesses an overall spin. This overall 
spin is important. Quantum theories suggest that nucleus with spin has 
different orientations. These orientations are actually nuclear energy levels 
called ‘spin states’ where ‘spin’ refers to the fact that the magnetism of a 
given nucleus may be considered to arise from the spinning motion of its 
electrical charge (Bothwell JH and Griffin JL, 2011). In the absence of an 
external magnetic field, these orientations are of equal energy, but when a 
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Figure 10. Free induction decay (FID) and its Fourier tranformation . The FIDs may be simplified 
into the frequency domain, using a transformation technique called Fourier transformation. 
In the case of NMR, the nucleus is in a magnetic field and the initial 
populations of the energy levels are determined by thermodynamics, as 
described by the Boltzmann distribution. This means that lower energy 
levels will contain slightly more nuclei than higher levels. It is possible to 
excite these nuclei into higher levels, by electromagnetic radiation, which is 
observable by NMR signal. This signal is called free induction decay (FID). 
FID is a non-equilibrium nuclear spin magnetisation precessing about the 
magnetic field. Precessing is the motion of the axis of a spinning body, 
such as the wobble of a spinning top, when external force exists and acts 
on the axis. The FIDs may be simplified into the frequency domain, using a 
transformation technique called Fourier transformation (Figure 10). Fourier 
transformation is usually present in the form of a one-dimensional (1D) or 
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The energy difference between spin states depends on nuclear 
environment. Excited nuclei from one element, but in different nuclear 
environments, will emit slightly different radiofrequency (RF) wavelengths 
of electromagnetic radiation. In NMR, the energy of the emitted 
electromagnetic radiation is expressed as chemical shift, defined as the 
position of a peak on the spectrum. The exact value of chemical shift 
(usually given in parts per million; ppm) gives a reasonable indication of the 
molecule’s identity. In order to set the scale of the spectrum, an internal 
standard (IS) is needed. This IS is often trimethylsilyl (TMS) or trimethylsilyl 
propionate (TSP). TMS or TSP are used because are the most shielded 
molecules and all their protons are equivalent. Therefore, it should show up 
as one peak which can be used to set the 0 ppm mark on the spectrum 
(Bothwell JH and Griffin JL, 2011). 
Before the determination of which peaks correspond to specific nuclei, the 
scale for the chemical shifts of the spectrum must be set. Each molecule 
has a characteristic number and pattern of these peaks and sub-peaks. 
That is why a simple comparison of unidentified peaks with standard 
reference spectra will often allow identification of the metabolites in a 
sample. A number of NMR spectral databases have been set up for helping 
this metabolite assignation. One of the most known databases is the 
Human Metabolome Database (Wishart DS et al., 2007). 
Today, NMR spectroscopy has become one of the most powerful and 
flexible analytical techniques, being one of the few methods to give 
analytical information from the internal environment of living tissues. NMR 
can quantitatively analyze mixtures containing known compounds. In the 
case of unknown compounds, NMR can be used either to match against 
spectral libraries, such as previously mentioned, or to directly determine 
molecules basic structure. Once the basic structure is known, NMR can be 
used to determine molecular conformation in solution as well as studying 
physical properties at the molecular level like conformational exchange, 
phase changes, solubility, and diffusion (Bothwell JH and Griffin JL, 2011). 
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A NMR spectrum of a biofluid or tissue is extremely complex, consisting of 
thousands of well-resolved signals. Their intensities are related to the 
concentration of the metabolites in the sample. Moreover, NMR is applied 
not only to biofluids and tissues extracts, but also to intact tissue (cell 
cultures and/or red blood cells (RBC) suspensions), named high resolution 
magic angle spinning (HRMAS) 1H NMR spectroscopy (Griffin JL et al., 
2000). The physical properties of whole blood have serious limitations 
when tested by NMR. RBC yield more useful information on cell 
biochemistry. The NMR spectra of blood serum and plasma can provide an 
excess of useful biochemical information on both low molecular weight 
metabolites and macromolecular structure and organization. 
NMR-based metabolomics has the disadvantage of low metabolome 
coverage since it can only detect metabolites with high concentrations. 
Nevertheless, promising improvements have been made to resolve NMR 
spectroscopy sensitivity (Lenz EM and Wilson ID, 2007). 
 
3.3.2 Mass spectrometry 
MS is another analytical technique largely used in metabolomics. It 
becomes a very powerful tool for metabolic profiling when it is combined 
with a chromatographic technique and provides much better sensitivity in 
terms of the size of metabolome detected (Pan S et al., 2009).  
The chromatographic techniques commonly used and coupled to MS are 
GC and LC. Such techniques use a column that varies in length, diameter 
and chemical properties (stationary phases). A mixture of metabolites is 
separated as they travel through the column, depending on their different 
chemical properties. Metabolites elute at different time and then are 
subjected to MS analysis. MS mainly consists of 3 different components: 
ion source, mass analyzer and ion detector (Figure 11 ). 
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Figure 11. Mass spectrometer.  
 
Metabolites are ionised by ion source, and then transported to mass 
analyzer by magnetic or electric fields. A number of ionisation techniques 
are available, and include electron spray ionisation (ESI) and matrix-
assisted laser desorption/ionisation (MALDI). Different ionisation 
techniques are used depending on the nature of the samples under 
analysis (gas, liquid or solid). Molecular ions are further separated by mass 
analyzer according to their mass-to-charge ratio (m/z). Different 
configurations of ion source and mass analyzer are frequently used in the 
research. They differ in design and performance, and each one has its own 
strengths and limitations. These MS analysers can be stand alone or, in 
some cases, put together in tandem mass spectrometry (MS/MS) 
(Aebersold R and Mann M, 2003). A molecular ion with a specific mass is 
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Figure 12. Gas chromatography -mass spectrometry.  
generate ions fragments and get separated in the second mass analyzer 
(Dettmer K et al., 2007). 
 
3.3.2.1 Gas chromatography-mass spectrometry 
GC-MS has been widely used to analyze volatile and thermally stable 
metabolites and acquire high separation efficiency (Figure 12). 
 
Many metabolites might contain polar functional groups and might be 
thermally labile at temperatures required for their separation or might not 
be volatile at all. Therefore, derivatization prior to GC analysis is necessary 
to extend the application range of GC based methods. The majority of GC 
methods rely on derivatization with an oximation reagent followed by 
silylation, or solely silylation. The additional derivatisation step may 
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is an overall sensitive analytical approach and metabolites are separated 
and detected with high resolution (Koek MM et al., 2011). 
 
3.3.2.2 Liquid chromatography-mass spectrometry 
LC-MS does not require volatilized samples, thus it is not limited to 
particular classes of metabolites. LC-MS is the most sensitive metabolic 
profiling tool, and can operate in both positive electronspray ionization 
(ESI) and negative ESI to ensure the maximum coverage of metabolites 
detected (Lu W et al., 2008). 
Metabolite extraction from each biofluid sample is required before the 
injection into the LC column. The flow liquid carries compounds through the 
column. The column retains metabolites based on physical properties, and 
the different metabolites reach the mass spectrometer at different times. 
Ion abundances for each individual mass are measured relatively to the 
time each extract is injected to the chromatography column and the time of 
elution of that extract (retention time). Calculation of the area under the 
chromatographic peak for a particular mass and retention time provides a 
measurement of the quantity of the eluted metabolite at that time. 
LC-MS suffers from a matrix effect known as ion suppression. Ion 
suppression causes errors in the quantification of metabolites of interest. 
Less volatile compounds are capable of altering the efficiency of droplet 
formation or evaporation, consequently changing the amount of charged 
ions that reaches the detector (Annesley TM, 2003). 
 
3.3.2.2.1 Ultra performance liquid chromatography coupled to 
tandem mass spectrometry 
Ultra performance liquid chromatography (UPLC), which employs sub-2-µm 
porus particle columns, gives superior sensitivity and resolution compared 
to the conventional LC (Want EJ et al., 2010). The sub-2-µm stationary 
phases operate at high linear mobile-phase velocity and the sensitivity is 
increased when combined with MS. This allows the detection and 
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Figure 1 3. Ultra performance liquid chromatography coupled to tandem mass spectrometry.  
UPLC-MS/MS provides physical separation of metabolites, introducing different compounds into the 
mass spectrometer at different times. Chromatography decreases analysis speed but offers two main 
benefits: metabolites with identical masses but different retention times can be distinguished, and the 
separation of metabolites from interfering substances allows for improved quantitative accuracy. 
Adapted figure from: (Last RL et al., 2007) 
identification of more impurities in comparison to traditional HPLC 





Nowadays, there are some exciting approaches based on platform 
developments and incipient trends pointing towards a convergence of the 
“untargeted-discovery” and “targeted-verification” dichotomy. The 
technological developments in progress, such as faster separations, more-
effective ion sources, higher MS resolution, and detectors with higher 
dynamic ranges, will increasingly allow broad untargeted measurements 
that retain the benefits of targeted measurements (Smith RD, 2012). For 
example, for targeted metabolic profiling analyses, two steps of mass 
spectrometry (MS/MS) filter out interfering signals, after molecular ions are 
broken into fragments, between the mass-analysis steps. Reductions in 
background interference by the MS/MS technique allow for more rapid and 
accurate metabolite analyses, which are necessary in large-scale 
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metabolite-profiling studies (Figure 13). The coupling of UPLC technique to 
MS/MS further enhances specificity and provides an improved signal-to-
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Chapter 4.  Research Studies  
In the present work, we are particularly interested to study: 
1. The effect of natural products, with unknown anti-inflammatory 
(peanut extract) and endothelial function properties (alpha-
tocopherol; AT) on the modulation of risk factors for inflammation 
and endothelial dysfunction, after their incubation in cellular 
models. 
 
2. The characterization of two matrices of biofluids, such as RBC and 
plasma, by means of metabolomics techniques and their 
application into the novel nutritional biomarkers investigation. 
 
For this reason, it is of utmost importance to introduce specific background 
knowledge of the field. These concepts are organized based on the three 
studies performed during the present work. 
 
 
4.1 Inhibition of the Transcription factor c-Jun by the 
MAPK family, and not the NF- κB Pathway, Suggests that 
Peanut Extract has Anti-inflammatory Properties ( Study 1 ) 
 
4.1.1 Lipopolysaccharide such as pro-inflammatory inductor of 
atherosclerosis 
Atherosclerosis is a complex inflammatory process involved in CVD, the 
principal cause of morbidity and mortality in industrialized countries 
(Gerszten RE et al., 2011). Inflammation is characterized by the presence 
of monocytes/macrophages and T lymphocytes in the atheroma plaque 
(Ross R, 1999a). Monocytes promote atherosclerosis via production of 
various key mediators such as TNF-α. TNF-α is commonly found in 
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Figure 1 4. LPS stimulation of monocytes activates signaling 
pathways and transcription factors. LPS stimulates the activation of 
various MAPK pathways, including the ERK, JNK, and p38 pathways. 
These pathways directly or indirectly phosphorylate and activate 
various transcription factors. In addition, LPS activates the IKK 
pathway which in turn phosphorylates IκBs. Subsequent degradation of 
IκBs permits nuclear translocation of NFκB/Rel complexes, such as 
p50/p65. Source: (Guha M and Mackman N, 2001) 
atherosclerotic lesions contributing to the inflammatory process (Katsume A 
et al., 2011). Concentrations of TNF-α are increased in patients with 
increased risk of atherosclerosis (Devaraj S et al., 2002).  
The mechanisms 
underlying the first 





have been well 
described (Gee K et 
al., 2002). The 
exposure of cells to 
LPS, which is a major 
component of the 
outer membrane of 
Gram-negative 
bacteria, triggers the 
binding of LPS to the 
LPS bearing protein 
(LBP) and is 
transferred to the 
CD14 at the cell 
surface. LPS then interacts with the signaling toll-like receptor 4 (TLR4) 
and the accessory protein MD-2. LPS stimulates the activation of various 
mitogen-activated protein kinase (MAPK) family pathways, including the 
extracellular signal-regulated kinase (ERK) 1 and 2, c-Jun N-terminal 
kinase (JNK), and p38 pathways. These pathways directly or indirectly 
phosphorylate and activate various transcription factors including Elk-1, c-
Jun, c-Fos, ATF-1, ATF-2, SRF, and CREB. In addition, LPS activates the 
IKK pathway which in turn phosphorylates IkBs. Subsequent degradation of 
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Figure 15. Structure of TNF -α. Transmembrane TNF-α is composed of an extracellular domain, a 
transmembrane domain and an intracellular domain. Mature TNF-α (soluble TNF-α) is cleaved from 
transmembrane TNF-α by TACE (black arrow). The transmembrane domain of transmembrane TNF-
α is shaded as well and, the intracellular domain is translocated into the nucleus to possibly modulate 
gene expression of the TNF-α-bearing cells. Adapted figure from: (Horiuchi T et al., 2010) 
IkBs permits nuclear translocation of nuclear factor-κB (NF-κB) complexes 
such as p50/p65 (Guha M and Mackman N, 2001). The PI3K-Akt pathway 
phosphorylates and activates p65 via an unknown kinase. In the nucleus, 
activated transcription factors bind to recognition elements in the promoter 
regions of inflammatory and immune genes (Figure 14). These include pro-
inflammatory cytokines, chemokines, inflammatory enzymes and adhesion 
molecules such as TNF-α (Barnes PJ and Karin M, 1997). 
 
4.1.2 TNF-α production by LPS stimulated monocytes 
TNF-α is assembled intracellularly to form a trans-membrane protein which 
contains a cytoplasmic domain, a trans-membrane segment and an 
extracellular region (Figure 15 ). There are two forms of TNF-α: the full-
length type II membrane-bound form, and the soluble form resulting from a 
proteolytic cleavage that releases the active C-terminal portion from the cell 
surface to the extracellular medium (Black RA, 2002). This proteolysis 
converts membrane bound “pro” form (pro-TNF-α) into its biologically active 
soluble form (Figure 16); sTNF- α (Ishisaka R et al., 1999; Horiuchi 
T et al., 2010). This proteolysis is supervised by a protease. TNF-α 
converting enzyme (TACE) also called ADAM17 (a disintegrin and 
metalloprotease) family of proteins possess α-secretase activity 
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Figure 1 6. TACE mediated ectodomain shedding of TNF -α. 
LPS-induced TNF-α processing by TACE. Adapted figure from: 
(Ramana KV, 2010) 
Figure 1 7. TACE. Domain structures from TACE. A 
single transmembrane domain defines the topology of 
TACE as a class-I membrane protein with Pro, 
Catalytic and Cys domains. Source: (Bahia MS and 
Silakari O, 2010) 
(Katakowski M et al., 
2007; Zheng X et al., 
2007). TNF-α can be 
cleaved by TACE to 
release a soluble, 
mature subunit (sTNF-α; 
17 kDa) that becomes 
biologically active (Tang 
P et al., 1996; Black RA 
et al., 1997; Ramana KV, 
2010; Chou YC et al., 
2011). 
TACE is a multi domain 
type 1 transmembrane 
protein (Figure 17). 
TACE requires cleavage of its pro domain to become a “mature” and fully 
active protease. TACE can be activated by nitrosation, alkylation and 
oxidation, resulting in the 
dissociation of cysteine thiol-
zinc linkage and thereby 
release of the pro domain 
inhibitory function. 
Pro domain removal mainly 
occurs by autocatalysis and 
action of furin of related pro-
hormone convertases in Golgi 
compartment. The role of 
disintegrin domain in TACE is 
not known but it may have an 
adhesion function as this 
domain has been shown to 
interact with integrins in some other ADAMs. 
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Figure 18 . Possible relationships to transcriptional and post -transcriptional regulation of TNF -
α expression.  
The function of cytoplasmatic tail is not definite but it seems to be involved 
in the control of TACE's intracellular trafficking. Most important, the catalytic 
domain of Zn metalloproteases possesses a conserved zinc ligating 
sequence. TACE is a promising target for treatment of many inflammatory 
diseases (Ramana KV, 2010). 
Although the mechanism of the LPS-induced TNF-α signaling pathway via 
MAPK and NF-κB activation has been well described in monocytes (Beutler 
B, 2000; Witkamp R and Monshouwer M, 2000; Dayer JM et al., 2005), 
there is a gap in the knowledge of which molecules are involved, starting 
from the TNF-α mRNA expression and extending to the extracellular 
protein secretion of TNF-α. The first route of diversification of proteins is at 
the transcriptional level (by mRNA splicing and including tissue-specific 
alternate splicing, editing and stability (Cheneval D et al., 2010; 
Subramaniam D et al., 2011)). The second route to proteome expansion is 
the post-translational modification (PTM) of proteins at one or more sites 
(Walsh CT et al., 2005). Therefore, NF-κB and MAPK family needs to be 
LPS
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Figure 1 9. Peanuts.  
evaluated more thoroughly so that the inflammatory route that follows TNF-
α in atherogenic inflammation may be better understood. Targeting the 
proximal triggers such as TNF-α would be the more promising strategy for 
interrupting inflammation in atherogenesis (Ishisaka R et al., 1999). 
Possible relationships to transcriptional and post-transcriptional regulation 
of TNF-α expression mediated by NF-κB or MAPK family transcription 
factors is shown in Figure 18. 
Further, BAY 11-7082 ((E)3-[(4-methylphenyl)sulfonyl]-2-propenenitrile; 
BAY) is a synthetic molecule that has demonstrated anti-inflammatory 
activity by inhibiting the NF-κB and MAPK pathway that can be used as 
control product in comparing the anti-inflammatory effects of test molecules 
(Barnes PJ and Karin M, 1997; Guha M and Mackman N, 2001; Black RA, 
2002). However, the effect of BAY on TACE activity on monocyte THP-1 
cells has not been evaluated, to date. 
 
4.1.3 Natural extracts or compounds such as anti-inflammato ry 
substratum 
Some natural extracts (or compounds) of certain foods have anti-
inflammatory properties and in vitro cellular models can be used to screen 
for biological activity (Singh U et al., 2005). When a natural extract or 
compound shows anti-inflammatory effects, the different mechanism of 
action ought to be explored systematically in the same cell model so as to 
improve the methodological reliability (Essafi-Benkhadir K et al., 2012). 
Dried fruits, for example, are rich in polyphenols and exert beneficial effects 
on inflammation and, as a result, decrease CVD progression (Kris-Etherton 
PM et al., 2002; Calixto JB et al., 2003; Ortega RM, 2006). 
 
The polyphenol-rich peanut extract  
There have been many studies published on the harmful 
effects of peanuts (Figure 19), such as the allergy 
promoted by this natural extract (Chen X et al., 2011; 
Moverare R et al., 2011; Schulz VJ et al., 2011). However, 
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there is a paucity of studies addressing its potential beneficial effect on 
atherosclerosis resulting from its anti-inflammatory activity. 
 
4.2 Alpha-Tocopherol and BAY 11-7082 Reduce Vascular 
Cell Adhesion Molecule In Human Aortic Endothelial Cells 
(Study 2 ) 
 
4.2.1 TNF-α such as inductor of endothelial dysfunction in 
atherosclerosis 
Atherosclerosis can be considered the clinical endpoint of an inflammatory 
process and endothelial dysfunction. The binding of monocytes to the 
vascular endothelium is mediated by cross-linkage of cell adhesion 
molecules (CAMs) such as VCAM-1, E-selectin and/or ICAM-1. The cell 
surface expression of these molecules is greatly increased in 
atherosclerotic lesions as a result of stimulation by pro-inflammatory 
cytokines such as TNF-α. This cytokine has been selected as a stressor 
molecule in assessing the underlying mechanisms because it induces 
release and surface expression of CAMs, all of which contribute to the 
inflammatory process and endothelial dysfunction (Amberger A et al., 1997; 
Wu D et al., 1999; Zhou Z et al., 2005; Davis PA et al., 2006; Lee G et al., 
2006). Further, there is in vivo evidence of increased VCAM-1 production in 
animal models of inflammation (Lee G et al., 2006). 
 
4.2.2 The role of cellular adhesion molecules 
Endothelial CAMs are known to be up-regulated in atherosclerotic 
endothelium in an environment of circulating blood. They participate in 
leukocyte recruitment and, subsequently, in atherosclerosis progression 
and/or tissue damage (Dagia NM et al., 2004). 
E-selectin is an inducible endothelial cell surface glycoprotein of the 
selectin family of adhesion molecules. It mediates the binding of 
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Figure 20 . Molec ular structure 
of BAY 11-7082.  
neutrophils, eosinophils, monocytes and T lymphocytes to the endothelium 
(Vannini N et al., 2008). 
VCAM-1 and ICAM-1 are members of the immunoglobulin superfamily of 
CAMs. They mediate lymphocyte adhesion to major elements of the aortic 
wall such as endothelial cells and vascular smooth muscle cells (Lawson C 
and Wolf S, 2009).  
Induction of these three CAMs (VCAM, ICAM and E-selectin) by TNF-α is 
regulated at the level of gene transcription, and requires the transcription 
NF-κB. Located in the cytoplasm of cells in an inactive form in close 
association with the inhibitor IκB-α, NF-κB binds to regulatory regions 
within promoter regions of the VCAM-1 gene (Pierce JW et al., 1997; 
Dieguez-Acuna FJ et al., 2004) via a process involving the phosphorylation 
and degradation of IκB-α (Pierce JW et al., 1997; Spiecker M et al., 1997; 
Izban KF et al., 2000).   
In vitro studies indicate that VCAM-1, E-selectin and ICAM-1 are involved 
in adhesion of eosinophils, monocytes and T lymphocytes via their cell 
surface (Martin KR et al., 2000). Proteolytic cleavage of membrane-bound 
CAMs result in the release of their soluble forms: soluble CAMs (sCAMs) 
i.e. sVCAM-1, sE-selectin and sICAM-1 (Leeuwenberg JF et al., 1992; Just 
N et al., 2003; Dagia NM et al., 2004; Constans J and Conri C, 2006). 
BAY is an anti-inflammatory and antioxidant molecule that selectively and 
non-reversibly inhibits the inducible phosphorylation of IkB-α in human 
pancreatic MIA PaCa-2 cancer cells (Kamthong PJ and Wu M, 2001) and 
endothelial cells (Kopp E and Ghosh S, 1994). As such, IkB-α avoids being 
degraded, resulting in a high level of cytosolic NF-κB sequestered by IkB, 
together with decreased transcription and surface expression of the 
adhesion molecules (Kamthong PJ and Wu M, 2001). 
However, the effect of BAY (Figure 20) on VCAM-1 
mRNA expression and its soluble protein (sVCAM-
1) on endothelial dysfunction induced by TNF-α in 
human aortic endothelial cells (HAEC) has not, as 
yet, been evaluated in detail. 
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Figure 21 . Molecular structure of Vitamin E 
(alpha -tocopherol).  
4.2.3 Natural extracts or compounds may improve endothelial 
dysfunction 
Some natural compounds or extracts of certain foods have been described 
as reversing endothelial dysfunction (Wu D et al., 1999; Martin KR et al., 
2000; Chen YH et al., 2001; Chen JW et al., 2003; Davis PA et al., 2006). 
Prior to evaluating these functions in in vivo studies in animals or/and 
human subjects, in vitro cell models are developed to test the effects of 
these natural extracts (or compounds) based on the expression of cellular 
adhesion molecules in TNF-α-stimulated cells. As such, in vitro models 
facilitate the study of cells under controlled conditions and can be used as 
tools to examine the effects of various natural or synthetic 
pharmacologically active compounds. 
Dietary factors play significant roles in the etiology of atherosclerosis by 
influencing inflammatory and endothelial dysfunction processes associated 
with the development of this disease. 
 
The AT molecule 
Vitamin E, especially AT (Figure 21) the main fat-soluble dietary 
antioxidant (Saremi A and Arora R, 2010), is very effective in reducing the 
adhesion of monocytes to HAEC in vivo and in vitro (Liu L et al., 2004).  
Several studies have demonstrated 
that vitamin E decreases cytokine-
stimulated HAEC production of 
chemokines such as sVCAM-1, 
sICAM-1 (Lee G et al., 2006), 
interleukine-6 (IL-6), and IL-8 (Liu 
L et al., 2004) when stimulated 
with IL-β. Also, VCAM-1 mRNA expression level is consistently elevated 
when incubated for between 6 and 24h with TNF-α (10 ng/mL) and LPS (10 
µg/mL) in human umbilical vein endothelial cells (HUVEC); the levels 
remaining high under these conditions (Raab M et al., 2002; Tribolo S et 
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Figure 22. Whole blood separation . Serum or plasma represents 55% of total blood; leukocytes and 
platelets less than 1% and RBC or erythrocytes about 45-50% of whole blood. 
al., 2008). However, effects of AT on endothelial dysfunction induced by 
TNF-α in HAEC are not well documented.  
Some of the foods with high AT content, and the bioavailability of this form 
of vitamin E is highest, are ground hazelnuts, canola-based margarine, 
wheatgerm oil and other vitamin E-rich foods such as avocado and 
pumpkin (McGavin JK et al., 2001).  
 
4.3 Biomarkers of Food Intake and Metabolite Differences 
Between Plasma and Red Blood Cell Matrices; a Human 
Metabolomic Profile Approach ( Study 3 ) 
 
4.3.1 Blood samples 
Whole blood is a biofluid containing RBC. It has active metabolism, mainly 
the glycolytic or Krebs cycle, catalyzed by a range of enzymes. The whole 
blood contains about 45-50% of RBC and the abundance of other cell types 
is around 1%. Serum and plasma represents about 55% of total blood and 
consist mainly of water with a number of distinct molecules. These include 
macromolecules such as proteins, lipids, and immunoglobulins. 
Centrifugation


























(2000 g / 15 min / 4ºC)
 
UNIVERSITAT ROVIRA I VIRGILI 
EFFECT OF FOOD EXTRACTS AND BIOACTIVE FOOD COMPOUNDS ON THE MECHANISM OF ATHEROSCLEROSIS 
AND NUTRITIONAL BIOMARKERS 
Úrsula Catalán Santos 





Serum is the yellowish fluid obtained after untreated whole blood 
centrifugation and separation into its solid and liquid components. Serum 
tubes may include a gel with intermediate density between blood cells and 
serum. When the tube is centrifuged, a layer of the gel covers the blood 
cells sink to the bottom of the tube,, and the serum is left on the top. Serum 
is depleted in the major clotting protein precursor and is consequently less 
viscous than plasma (Figure 22). Plasma is separated from whole blood 
after the addition of an anticoagulant to the tube extraction that is normally 
ethylenediaminetetraacetic acid (EDTA), lithium heparin or sodium citrate. 
A specific analytical approach is required to analyse a biofluid, a tissue 
extract or an intact tissue. 
 
4.3.2 Blood sample collection 
Intrinsic changes could arise from blood sample collection (sodium citrate 
vs. lithium heparin as anticoagulants) and the subsequent comparison 
between aqueous vs. organic phases of two different matrices such as 
plasma vs. RBC. In the current metabolomics study, analyses of plasma 
and RBC samples obtained from both anticoagulant tubes will be compared 
based on a battery of untargeted and several targeted analyses covering 
different families of compounds with potential interest in the field of 
nutrition. 
Hence, sensitive methods such as, have been used in metabolomics to 
detect and quantify biomarkers of nutrient intake and/or dietary patterns as 
well as to assess the relationships between nutrition and the risk of disease 
(Puiggros F et al., 2011). The combination of various ‘omics’ technologies 
(systems biology) will greatly facilitate the discovery of new biomarkers 
associated with specific nutrients of dietary factors (Zhang X et al., 2008). 
The identification and optimization, in plasma or in RBC, of biomarkers of 
dietary consumption can extend the evaluation of nutritional status (Doring 
Y et al., 2012). 
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4.3.3 Plasma and RBC matrices 
In human studies, the volume of blood that can be accessed from the 
individual for diagnostic and/or research purposes is limited and, since 
most analytes are measured in plasma or serum, the erythrocytes or RBC 
are usually discarded. However, RBC could be an important source of 
nutritional information not previously accessed (Darghouth D et al., 2010). 
New dietary biomarkers measured in RBC (Jenab M et al., 2009) may 
reflect longer-term markers of nutritional intake compared with plasma or 
urine and, as such, their measurement extends the emerging field of 
nutritional metabolomics.  
Traditionally, serum lipids have been studied in lipoproteins separated by 
ultracentrifugation. Further analyses have been limited to the distributions 
of several lipid species such as cholesterol, phospholipids and triglycerides. 
More recently, metabolomics empowers the study of the full spectrum of 
lipids and lipoproteins in greater detail (Orešič M, 2009). Quantitative 
and/or qualitative measurements of dietary fatty acid (FA) are key 
nutritional factors in CVD evaluation and prevention. The FA profile, as 
measured in RBC, reflects the medium-term dietary intake (a matter of 
weeks) (Shearer GC et al., 2009) while plasma FA levels reflect more 
recent intake (matter of days). As such, under certain circumstances, the 
RBC profile may provide more valuable information (Hodson L et al., 2008; 
Assies J et al., 2010; Caspar-Bauguil S et al., 2010). FA composition of cell 
membranes is dependent on dietary fat intake as well as that from 
intermediate metabolism (Fuhrman BJ et al., 2006). For example, blood 
concentrations of eicosapentaenoic acid (EPA), and docosahexaenoic acid 
(DHA) n-3 are appropriate biomarkers of FA from fish intake (Arab L and 
Akbar J, 2002; Arab L, 2003; Kuriki K et al., 2006). RBC FA vs. plasma FA 
profiles could provide differential FA biomarkers of not only fish intake but 
also dairy products. However, this hypothesis has not been explored 
systematically, to date. 
Other molecules such as polyphenols reflect food intake of, mainly, fruits 
and vegetables. Food rich in polyphenols have protective effects against 
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chronic diseases such as CVD. Polyphenols are bioactive compounds that 
display several biological activities, including, anti-oxidant and anti-
inflammatory properties (Gonzalez R et al., 2011), and can exert their 
effects on RBC (Paiva-Martins F et al., 2009; Hapner CD et al., 2010; 
Koren E et al., 2010; Rizvi SI and Pandey KB, 2010). There have been 
studies assessing the polyphenols associated with RBC (Fiorani M et al., 
2003; Maccaglia A et al., 2003; Koren E et al., 2010) but, to the best of our 
knowledge, the individual basal types and concentrations of polyphenols of 
human RBCs have not been evaluated. 
Analytical methods are being developed to describe metabolic profiles as 
indicators of dietary patterns, dietary changes or effectiveness of dietary 
interventions (Sengupta A and Ghosh M, 2011). Traditional dietary 
assessment methods are indirect and remain difficult to prove effectiveness 
of dietary interventions and, often, can obscure disease risk associations 
(Jenab M et al., 2009). 
Challenges associated with the use of metabolomics technology in human 
nutritional research involve, among others, the standardization of sample 
collection (Gibney MJ et al., 2005). This becomes mandatory when large-
scale human nutritional metabolomics studies are planned. Conversely, 
serum/plasma or other bio-fluid availability is also an issue in such studies 
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Hypothesis  
We hypothesize that atherosclerosis-specific biological cell approach, such 
as THP-1 monocytes and HAEC, could be used successfully to study the 
mechanism-of-action of food extracts and/or bioactive compounds while 
assessing their effects on inflammation and endothelial dysfunction. 
Further, we hypothesize that two different biological samples, RBC and 
plasma from the same blood extraction, can provide complementary 
metabolomic profile information. 
 
Objectives:  
1.   To standardize experimental methodology for testing the mechanism-
of-action of food extracts (such as polyphenol-rich peanut extract) and 
bioactive compounds (such as AT) while assessing their effect on 
inflammation and endothelial dysfunction. The procedures used are: 
a) THP-1 monocyte system; a LPS-inflammation model exposed to 
peanut extract. Measurements include the TNF-α cascade: NF-κB 
and MAPK family, TNF-α mRNA expression, TNF-α mRNA 
stability, TACE activity and total TNF-α protein including intra- and 
extracellular protein (Study 1 ). 
b) TNF-α-stimulated HAEC; an endothelial dysfunction model to study 
the effect of the AT molecule on different CAMs such as: ICAM-1, 
VCAM-1 and E-selectin. Measurements were conducted at the 
mRNA and soluble protein level to explore their individual 
involvements in leukocyte adhesion to endothelium (Study 2 ). 
 
2.    To apply and standardize high-throughput metabolomic analytical 
techniques such as NMR spectroscopy, GC-MS and UPLC-MS/MS to 
characterize the metabolomic profile of human RBC and human plasma 
(Study 3 ). 
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1. Inhibition of the Transcription factor c-Jun by the 
MAPK family, and not the NF- κB Pathway, Suggests that 
Peanut Extract has Anti-inflammatory Properties ( Study 1 ) 
 
1.1 Reagents  
LPS (Escherichia coli O55:B5), dimethyl sulfoxide (DMSO) and actinomycin 
D (Act D) from Streptomyces sp. were obtained from Sigma-Aldrich 
(Madrid, Spain). Ethanol was obtained from Panreac (Barcelona, Spain). 
Phosphate-buffered saline (PBS) was purchased from Gibco (Barcelona, 
Spain). Radio-immunoprecipitation assay lysis buffer (RIPA) was generated 
using the following base ingredients (50mM Tris-HCl, pH 7.52; 150mM 
NaCl; 0.1% SDS; 1% Nonidet; 0.5% sodium deoxycholic acid) and 
complete protease inhibitor cocktail (CPIC; Roche Applied Science, 
Valencia, Spain). To preempt cytotoxicity, ethanol and DMSO 
concentrations never exceeded 0.1% (v/v) in culture media. Acetone and 
hexane were purchased from JT Baker (Tarragona, Spain). 
 
1.2 Peanut extract preparation and composition  
Peanut extract was kindly supplied by La Morella Nuts (Castellvell del 
Camp, Tarragona, Spain). The process of extraction was according to the 
method of Ortega and Monagas (Monagas M et al., 2007; Ortega N et al., 
2008). Briefly, the extract was obtained from the skins of roasted peanuts. 
The peanut skins were ground in a laboratory mill and freeze-dried before 
extraction with phenol. To achieve maximum extraction efficiency, the raw 
material was first defatted with hexane (ratio of 1:10; Wskin:Vhexane) for 15 
min in an ultrasound sonicator (Selecta, Tarragona, Spain) containing ice to 
avoid warming. The defatted skins were then extracted thrice with hexane, 
and filtered. The organic solvent was removed by rotary evaporation (Büchi 
R-210, Tarragona, Spain) under partial vacuum. The phenolic extract was 
obtained by treating the defatted skin with a solution of acetone in MilliQ 
water (1:1, v/v) in a ratio 1:10 (Wskin/Vsol). Initially, a soaking process is 
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Figure 23 . THP-1 monocyte cells.  
needed with manual mixing. The extraction process proceeds in an 
ultrasound sonicator with ice to avoid warming. The extracting solvent is 
removed by vacuum filtration and the partially extracted skins are extracted 
three more times with the same extracting solution. The phenolic extracted 
fraction is obtained after removing the acetone solvent by rotary 
evaporation under partial vacuum. Finally, the aqueous extract is freeze-
dried in a lyophilizer (Cryodos Telstar, Tarragona, Spain) to obtain the 
peanut extract to be used in the experiments described. 
The bioactive peanut extract phenolic profile is composed by 39% 
flavonols, 37% flavanols and 24% phenolic acids, dissolved in 3.75% 
DMSO. 
 
1.3 Cell culture  
The THP-1 human monocyte cell line (Figure 23), derived from peripheral 
blood of a 1 year old male with acute monocytic leukemia, was purchased 
from Deutsche Sammlung von 
Mikroorganismen und Zellkulturen GmbH 
(DSMZ; Braunschweig, Germany). The 
THP-1 cell line, rather than human 
monocytes, was used so as to minimize 
inter- and intra-experiment variability. 
THP-1 cells were routinely cultured in a 
humidified incubator containing 5% CO2 
and 95% O2 at 37 ºC using RPMI medium 1640 + Glutamax-I (Gibco, 
Spain) supplemented with 20% of heat-inactivated fetal bovine serum 
(FBS; PAA, Labclinics; Barcelona, Spain) for the two first days followed by 
10% FBS + 100 U/mL penicillin and 100 mg/mL streptomycin for further 
growth and experiments. 
Dose-effect and time-response experiments with LPS, BAY and peanut 
extract were standardized in the course of establishing final experimental 
conditions. For example, THP-1 cells were plated at a density of 5x105 
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cells/mL for every experiment conducted, while 1x106 cells/mL was the cell 
density used for the determination of NF-κB and MAPK family. 
Subsequently, THP-1 cells were pre-incubated with peanut extract (5, 25, 
50 and 100 µg/mL), BAY (5µM) and/or the vehicle control (3.75% of 
DMSO) for 1h, depending on the study requirements. After 1h, LPS (500 
ng/mL) was added for 4h (for most experiments) or 1h (for NF-κB and 
MAPK family) or 2h (for TNF-α mRNA stability) to the cell culture medium 
to induce cell stimulation. Finally, supernatants were isolated and stored at 
-20 ºC for batched analyses to detect extracellular TNF-α protein, and to 
measure the activity of lactate dehydrogenase (LDH) release. Cell extracts 
were lysed in each experiment and stored at -80 ºC for batched 
measurement of NF-κB, MAPK family, TNF-α mRNA expression and its 
mRNA stability, intracellular TNF-α protein, and TACE activity. 
 
1.4 Cytotoxicity  
A colorimetric assay to measure the activity of LDH release (the LDH 
Cytotoxicity Detection Kit; Roche Applied Science, Mannheim, Germany) 
was used to determine cell cytotoxicity. Briefly, LDH is rapidly released into 
the cell-culture supernatant when the plasma membrane is damaged, and 
this provides an index of cellular cytotoxicity. LPS treatment was taken as 
the maximum stress status for the cells, and possible cytotoxicity. 
The control culture medium (RPMI-1640 + 10% FBS + LDH released from 
cells) has high OD at 492nm and is useful as an internal control. Results 
are expressed as mean optical density (OD) and standard deviation (SD) of 
the LDH absorbance produced by the cells under each of the treatment 
conditions. 
 
1.5 NF-κB (p65) and MAPK family transcription factor 
assay  
Activation of NF-κB (p65) and MAPK family from nuclear extracts was 
measured using the TransAm® NF-κB and MAPK family kit, respectively 
(Active Motif, Carlsbad, CA). Briefly, this is an enzyme linked immuno-
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sorbent assay (ELISA)-based assay during which, when nuclear or whole-
cell extract is added, the activated transcription factor-of-interest binds the 
oligonucleotide at its consensus binding site and is quantified using the 
linked antibody which is specific for the active form of the transcription 
factor being studied. The NF-κB and MAPK family detection was according 
to the manufacture’s instructions. Peanut extract at different concentrations 
(5, 25 and 100 µg/mL) or BAY (5 µΜ) were incubated with THP-1 for 1h 
and, then, the cells were stimulated with LPS (500 ng/mL) for a further 1h. 
Results were expressed as percentage (SD) of NF-κB or OD (SD) of MAPK 
family activity under each treatment condition. 
 
1.6 Analysis of mRNA expression by RT-PCR  
Messenger RNA (mRNA) of TNF-α was measured by reverse transcription-
polymerase chain reaction (RT-PCR) after total RNA had been isolated 
from cells. Cells were lysed with nucleic acid purification lysis solution and 
total RNA was isolated from cells using the ABI PRISM 6100 Nucleic Acid 
PrepStation extraction system (Applied Biosystems, Foster City, USA) 
following the manufacture’s protocol. Total RNA was quantified using 
Quant-itTM RNA Assay Kit. Using 2720 Thermal Cycler (Applied 
Biosystems, Foster City, USA), 0.5 µg of total RNA was reverse transcribed 
to cDNA at 42 ºC for 50 min, using Random Hexamers, SuperScript II 
reverse transcriptase and RNAse Out according to the manufacturer’s 
protocol. To determine the amount of TNF-α mRNA, quantitative real-time 
PCR was performed using the ABI PRISM® 7900HT Sequence Detection 
System (Applied Biosystems, Foster City, USA) with the following profile: 
95 ºC denaturing (20s), 40 cycles of extension at 95 ºC (1s), and 60 ºC 
(20s). TNF-α gene expression results were reported as increase/decrease 
using 2-∆∆Ct mathematical method, using glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) as housekeeping gene to normalize the results. 
The LPS-activated monocytes (500 ng/mL) were defined as the calibrator 
in these experiments, setting its value at 1 and the other conditions in 
relation to it. The expression of TNF-α mRNA in cultured THP-1 cells was 
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determined with and without LPS stimulation. We had previously examined 
the effects of BAY on the release of TNF-α, which is under NF-κB 
transcriptional control (Magness ST et al., 2004), together with peanut 
extract whose synthesis is unknown. Thus, the anti-inflammatory effect of 
the natural compound tested (peanut extract, in the present study) was the 
reduction of TNF-α mRNA of the cells incubated with the extract compared 
to the activation with LPS alone. Results were expressed as mean (SD) of 
TNF-α mRNA change compared to LPS alone. 
 
1.7 Stability of TNF- α mRNA  
Act D is a polypeptide antibiotic isolated from Streptomyces sp bacteria. 
Act D is used as a transcription inhibitor because its intercalation into DNA 
produces a physical obstruction to RNA polymerase transcription, and 
inhibits the elongation of RNA chains (Koba M and Konopa J, 2005). Half-
life/stability of TNF-α mRNA was measured after all experimental 
incubations of monocytes, mentioned above. After 2h of incubation with 
LPS, Act D (5µg/mL) was added to the medium. Incubation times with Act 
D were 30, 60, 120 and 180 min. At these times, the cells were lysed to 
obtain total RNA. Results were expressed as mean (SD) of TNF-α mRNA 
change compared to time 0 min for each experimental condition. 
 
1.8 Determination of total TNF- α protein concentration  
Total TNF-α protein concentration (extra- and intracellular) was determined. 
According to Black et al and Ishisaka et al (Ishisaka R et al., 1999; Black 
RA, 2002), the total TNF-α protein is the sum of extracellular TNF-α 
(soluble) plus intracellular TNF-α (cytoplasmic plus trans-membrane) 
protein. 
Extra- and intracellular TNF-α proteins were measured using human TNF-α 
ELISA kit (R&D Systems, Spain); the reported sensitivity of which was 5.5 
pg/mL. Results were expressed as mean (SD) pg/mL/106 cells. 
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1.8.1 Detection and quantification of extracellular TNF- α 
Supernatants of the experimental cell cultures were used to measure the 
extracellular TNF-α protein secretion. To determine the anti-inflammatory 
effect, the percentage reduction of TNF-α protein release is measured as 
the extracellular level because the biologically active form of TNF-α is the 
soluble form i.e. which exerts an effect in the organism. Thus, the anti-
inflammatory effect of the natural compound tested (in the present case 
that of peanut extract) was the difference between the levels of 
extracellular TNF-α protein secretion of those cells incubated with the 
extract, compared to the levels from LPS activation alone. 
 
1.8.2 Detection and quantification of intracellular TNF- α 
THP-1 cells were washed twice with phosphate buffered saline (PBS) 
(Jang CH et al., 2006), then ice-cold modified RIPA lysis buffer (50 µL/106 
cells, as described above) was added to lyse the cells. The insoluble 
material was removed by centrifugation at 16,000 x g at 4 ºC for 10 min 
(Oda T et al., 2006; Hu JH and Zhu XZ, 2007). The amounts of cytokine in 
cell lysate were measured as pg/mL produced from 106 cells. 
 
1.9 TACE (α-secretase) activity assay  
TACE activity from cell lysates (including cytoplasmic and trans-membrane) 
was determined by the SensoLyte® 520 TACE (α-secretase) Fluorimetric 
Activity Assay Kit (Anaspec, Fremont, CA, USA) under varying culture 
conditions. Cells were harvested and lysed using the assay buffer 
(containing 0.1%, v/v Triton-X 100) provided by the manufacturer. Protein 
content of cell lysate (cytoplasmic and trans-membrane) was determined 
using the Bradford protein assay. The kit was used according to the 
manufacturer’s protocol. Fluorescence of the cleavage product was 
measured in a fluorescence microplate reader using Synergy HT 
Fluorimeter (BioTek Instruments, Alcobendas, Madrid, Spain), with 
excitation wavelength set at 490 nm and emission wavelength at 520 nm. 
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Figure 24. Graphical abstract from s tudy 1. Inhibition of the Transcription factor c-Jun by 
the MAPK family, and not the NF-κB Pathway, Suggests that Peanut Extract has Anti-
inflammatory Properties. 
Results were expressed as mean (SD) relative fluorescence units (RFU) 
produced from TACE activity. 
 
1.10 Statistical analyses  
Two independent experiments were performed on different days. Samples 
were run in triplicate, and the data were pooled for each experiment. A total 
of six replicates were obtained for each experimental condition. All the 
results were analyzed with the Statistical Package for the Social Sciences 
(SPSS) software (version 19.0). 
Descriptive statistics (means and standard deviation) and analytical 
statistics (ANOVA and Bonferroni tests) were used to assess dose-
response effects. Statistical significance was set at P<0.05. 
The measurement of quality was precision repeatability (within-assay) and 
reproducibility (between-assay) as measured by standard deviation (SD), 
coefficient of variation (CV) and standard error of the mean (SEM). 
 
Figure 24 represents a graphical description of the design and  
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Figure 25 . Human aortic endothelial cells 
(HAEC). 
2. Alpha-Tocopherol and BAY 11-7082 Reduce Vascular 
Cell Adhesion Molecule in Human Aortic Endothelial Cells  
(Study 2 ) 
 
2.1 Cell culture  
HAEC (Cascade BiologicsTM, Portland, USA; Figure 25) at the 5 th passage 
were seeded on NunclonTM ∆ surface 12-well plates (for the mRNA 
assays), 24-well plates (for the protein assays) or 96-well plates (for 
adhesion assays) at density of approximately 12x103 of viable cells/mL. 
Cells were maintained for the first 24h in complete cell CM composed of 
M-200 medium supplemented with 
2% (v/v) low serum growth 
supplement (LSGS), 10 mg/mL 
gentamicin, 0.25 mg/mL 
amphotericin B (both purchased from 
Invitrogen; Paisley, UK), 100 U/mL 
penicillin and 100 mg/mL of 
streptomycin (both from Labclinics, 
Barcelona, Spain). The cells were 
grown to confluence at 37 ºC in a humidified incubator (Heracell 150; 
Madrid, Spain) with atmosphere containing 5% CO2. The medium was 
replenished every two days with fresh CM. Viewed under an Olympus 
IMT2 microscope (Barcelona, Spain), confluent monolayers displayed, 
after 5 days in culture, a typical monolayer phenotype of quiescent 
endothelial cells. All HAEC experiments were conducted at 37 ºC in a 
humidified atmosphere with 5% CO2.  
Jurkat T cell lymphocytes were purchased from Deutsche Sammlung von 
Mikroorganismen und Zellkulturen GmbH (DSMZ; Braunschweig, 
Germany). Jurkat T cells were cultured in RPMI medium 1640 + Glutamax-
I (Gibco, Spain) supplemented with 20% heat-inactivated FBS (PAA, 
Labclinics; Barcelona, Spain) for the two first days followed by 10% FBS + 
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100 U/mL penicillin and 100 mg/mL streptomycin for growth and the 
scheduled experiments. The Jurkat T cells were maintained until the cell-
cell adhesion assays. 
HAEC were pre-incubated with AT (10, 25, 50, 75 and 150 µM; Sigma 
Chemical Co., St. Louis, Mo, USA), and the respective vehicle control 
(absolute EtOH; Panreac, Madrid, Spain) for 6h, as recommended in the 
literature (Martin A et al., 1996; Zhang WJ and Frei B, 2002; Schleser S et 
al., 2006; Shaw DI et al., 2007; Tribolo S et al., 2008). Then, as and when 
required, TNF-α (1 or 10 ng/mL; Calbiochem, Darmstadt, Germany) and 
BAY (0.1 or 1 µM; Merck; Darmstadt, Germany) were added for 24h to the 
cell CM to induce cell stimulation. Finally, except for cell-cell adhesion 
assays, supernatants were collected, and stored at -20 ºC for batched 
measurements of the soluble forms of selected CAMs (sVCAM-1, sE-
selectin and sICAM-1), and to measure the activity of LDH released. Cells 
were lysed and stored at -80 ºC for batched CAMs mRNA expression 
measurement. Fluorescent intensity was the method used to measure cell-
cell adhesion. 
 
2.2 Cell viability and cytotoxicity  
Cell viability was assessed by morphology using phase contrast 
microscopy and by trypan blue exclusion (Merck & Co., Inc; Darmstadt, 
Germany). 
Cell cytotoxicity was assessed with Cytotoxicity Detection Kit LDH (Roche 
Applied Science, Mannheim, Germany). Briefly, LDH enzyme is rapidly 
released into the cell-culture supernatant when the plasma membrane is 
damaged. This results in a colorimetric reaction that can be measured at a 
wavelength of 492 nm. 
For these experiments, TNF-α treatment is considered as the maximum 
stress condition for the cells. 
Activity of LDH released from cells was measured in cell-free supernatants 
collected at two key points of the experiment: after 6h incubation with AT 
and after 24h incubation with TNF-α (alone or in the presence of BAY) at 
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the various concentrations. Results are expressed as mean absorbance 
and SD (error bars) of LDH produced by the cells under each treatment 
condition. 
 
2.3 Analysis of CAMs mRNA expression by real-time 
quantitative reverse transcriptase polymerase chain 
reaction (RT-PCR) in HAEC stimulated with TNF- α 
Dose- and time-course response experiments were performed by 
stimulating HAEC with TNF-α. Once the appropriate experimental 
conditions were established (i.e. the capacity to measure minimal 
decreases in CAMs mRNA expression that may be induced by the 
compounds under investigation; AT and BAY), we opted for 10 ng/mL (for 
E-selectin and ICAM-1) or 1 ng/mL (for VCAM-1) of TNF-stimulation over a 
culture period of 24h, and BAY 1 µM (for E-selectin and ICAM-1) or 0.1 µM 
(for VCAM-1). 
Cells were lysed with nucleic acid purification lysis solution and total RNA 
was isolated from cells using the ABI PRISM 6100 Nucleic Acid 
PrepStation extraction system (Applied Biosystems; Foster City, CA, USA) 
according to the manufacture’s protocol. Total RNA was quantified using 
Quant-itTM RNA Assay Kit and QubitTM fluorometer (Invitrogen; Paisley, 
UK). Using the 2720 Thermal Cycler (Applied Biosystems), 0.5 µg of total 
RNA was reverse transcribed to cDNA at 42 ºC for 50 min using random 
hexamers, SuperScript II reverse transcriptase and RNAse Out (Invitrogen) 
according to the manufacturer’s protocol. To determine the amount of 
VCAM-1, E-selectin and ICAM-1 mRNA, semi-quantitative RT-PCR was 
performed using the ABI PRISM 7900 Detection System (Applied 
Biosystems) with the following profile: 95 ºC denaturing (20 s) with 40 
cycles of extension at 95 ºC (1 s) and 60 ºC (20 s). Each sample was 
analyzed in triplicate and the cycle-threshold (Ct) was averaged from the 
values obtained in each reaction. VCAM-1, E-selectin and ICAM-1 mRNA 
expression results are reported as the increase (x-fold) using 2-∆∆Ct 
mathematical method. The GAPDH, (obtained from Applied Biosystems) 
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was used as housekeeping gene to normalize the results. TNF-α-activated 
endothelial cells were used as calibrator in these experiments; its value 
was set at 1 and the other conditions were in relation to this reference 
value. Results are expressed as the mean and SD (error bars) of CAMs 
mRNA change relative to TNF-α alone. 
 
2.4 Measurement of sCAMs protein secretion by HAEC 
stimulated with TNF- α 
Dose- and time-course response experiments were performed by 
stimulating HAEC with TNF-α. Once the appropriate experimental 
conditions were established i.e. the capacity to measure minimal decreases 
in sCAMs protein secretion that may be induced by the compounds under 
investigation (in the present case AT and BAY; 1µM), we opted for TNF-α 
at 10 ng/mL based on the concentrations used in previous reports with 
HUVEC (Shaw DI et al., 2007; Tribolo S et al., 2008) or with HAEC 
(Szekanecz Z et al., 1994; Amberger A et al., 1997; Chen YH et al., 2001; 
Zhang WJ and Frei B, 2002; Chen JW et al., 2003; Schleser S et al., 2006). 
At the conclusion of the experiments, cells and supernatants were 
separated by centrifugation (Multifuge 3L-R; Madrid, Spain) at 1500 x g for 
10 min at 4 ºC. The cell pellet/debris was discarded and the cell-free 
supernatants used for sVCAM-1, sE-selectin, sICAM-1 measurements 
using enzyme-linked immunosorbent assays (ELISA) according to the 
manufacturer’s protocol (for sVCAM-1 ELISA Kit, Diaclone, Besançon, 
France; for sE-selectin and sICAM-1, Quantikine ELISA kits from R&D 
Systems, Madrid, Spain). 
All experimental data were compared to the outcomes in the TNF-α-alone 
incubation, since this achieved the maximal secretion of sVCAM-1. A 
vehicle-alone control (vehicle for AT, absolute EtOH) was run in parallel 
and used as control in this experiment. Results are expressed as the mean 
sCAMs protein secretion and SD (error bars). 
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2.5 Calcein labelling of Jurkat T-cells  
Calcein acetoxymethyl ester (Calcein-AM, Molecular Probes, Eugene, OR, 
USA) was used to fluorescently label Jurkat T-cells. Calcein is a non-
fluorescent and lipophilic molecule which is cleaved by endogenous 
esterases, the resultant product fluorescence can be measured at 485 nm 
and 530 nm (excitation and emission wavelengths, respectively). 
The Jurkat T-cells were fluorescence labeled by incubating cells (25 x 106 
cells/mL) with a final concentration of 5 µM of calcein-AM for 30 min at 37 
°C and 5% CO2. After calcein-AM loading, the cells were washed twice with 
RPMI-1640 medium supplemented with 10% of FBS to remove excess dye. 
Cells were finally re-suspended in CM at a density of 2.5 x 106 cells/mL. 
 
2.6 Cell-cell adhesion assay  
HAEC were seeded until confluent in black 96-well tissue culture plates. 
Following the appropriate culture with AT and BAY, calcein-AM-labeled 
Jurkat T-cells were co-cultured (2.5 x 105 cells/well) with the HAEC 
monolayer for 1h at 37 ºC in a humidified atmosphere with 5% CO2. The 
non-adhered Jurkat T-cells were removed from the HAEC monolayer by 
washing twice with CM. Fluorescence in each well of the culture plate was 
measured with the Synergy HT Fluorometer (BioTek Instruments; 
Alcobendas, Madrid, Spain) (Roy S et al., 1998; Sen CK and Bagchi D, 
2001). Results are expressed as RFU and SD (error bars). 
 
2.7 Statistical analyses  
Data were expressed as the mean and SD (error bars) for sCAMs protein 
concentration and CAMs mRNA expression. Unless otherwise stated, all 
experiments were performed at least twice and each incubation condition 
was set-up in triplicate. Analysis of variance (ANOVA) with Bonferroni’s 
correction was used for multiple comparisons. A value of P<0.05 was 
considered statistically significant.  
A requisite for the analytical quality of the model is to control several 
aspects involved in the cellular process and analytical performance of 
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Figure 26 . Graphical abstract from study 2. Alpha-Tocopherol and BAY 11-7082 Reduce 
Vascular Cell Adhesion Molecule in Human Aortic Endothelial Cells. 
measurements. Thus, we evaluated the precision of the model by 
calculating the SD, the SEM and the coefficients of variation (CV). All the 
results were analyzed with the SPSS software (version 19.0). 
 
Figure 26 represents a graphical description of the design and 
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3. Biomarkers of Food Intake and Metabolite Differences 
between Plasma and Red Blood Cell Matrices; a Human 
Metabolomic Profile Approach ( Study 3 ) 
 
3.1 Ethics, subject recruitment and clinic visits  
Eligible male volunteers (N=10) between the ages of 20 and 70 were 
recruited from our volunteer center database. They were non-smokers with 
no other major CVD risk factors and were not using any medications and/or 
vitamin supplements. 
Participants provided written informed consent prior to enrolment into the 
study. Eligibility or exclusion was assessed by the attending physician 
based on a review of the clinical history, as well as physical and 
biochemical examination. The screening visit was to ensure that the 
participants were ostensibly healthy without any known illness. The study 
was approved by the Clinical Research Ethical Committee (Institutional 
Review Board) of the Hospital Universitari Sant Joan de Reus (Reference: 
10-04-29/4assN1) where the participants were recruited. The study 
protocol was in accordance with the Declaration of Helsinki and good 
clinical practice guidelines. 
 
3.2 Blood sample collection: plasma and RBC  
A fasting blood sample from each individual was collected into sodium 
citrate (~250 µL of 0.129M sodium citrate in 2.7 mL tubes) and lithium 
heparin (68 I.U.; Anorsa, Hospitalet de Llobregat, Barcelona, Spain) tubes. 
The samples and techniques used for this study are summarized in Table 
1. The samples were immediately centrifuged (2,000 x g, 15 min, 4 ºC) and 
then divided into separate aliquots of plasma and RBC. Plasma aliquots 
were stored at -80 ºC until analysis. RBC were washed three times with 
PBS (Invitrogen, Barcelona, Spain) and 1 µL of 1 mM butylated hydroxy 
toluene (BHT; Sigma-Aldrich, Madrid, Spain) / 100 µL of RBC was added to 
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prevent oxidation contamination, and then stored in aliquots at -80 ºC until 
analysis. 
Table 1. Qualitative and quantitative analysis of plasma and red blood cell (RBC) fractions.
1H NMR: Nuclear magnetic resonance spectroscopy; GC-MS: Gas chromatography - mass spectrometry






























With 10 subjects in the study, blood distributed into 2 different sample 
collection tubes (lithium heparin and sodium citrate), 2 matrices (plasma 
and RBC) and 2 fractions (organic and aqueous) the total number of 
samples processed (10 x 2 x 2 x 2) was 80. 
 
3.3 Biochemical parameters  
To confirm that the volunteers were ostensibly healthy a fasting blood 
sample was taken and the serum used for routine biochemical analyses. 
These included total cholesterol (mmol/L), triglycerides (mmol/L), direct 
HDL (mmol/L), apolipoprotein A1 (mg/dL), apolipoprotein B100 (mg/dL), 
glucose (mg/dL), uric acid (mg/dL), bilirubin (mg/dL), creatinine (mg/dL), 
urea (mg/dL), glutamic oxaloacetic transaminase (U/L), glutamic pyruvic 
transaminase (U/L), gamma glutamyl transferase (U/L) and alkaline 
phosphatase (U/L) were determined by routine laboratory methods using a 
Cobas Mira Plus autoanalyzer (Roche Diagnostic System, Madrid, Spain). 
 
3.4 Plasma viscosity  
Plasma samples (250 µL) from sodium citrate and heparin tubes were 
weighed and the density calculated. Plasma was then placed on an extra-
low-charge calibrated viscosimeter (Cannon Instrument Company, State 
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College, USA) and loaded on a Julabo ME-16G Visco Bath (Julabo 
Labortechnik GmbH, Seelbach, Germany) previously warmed to 37 ºC. The 
time taken for the plasma to pass from the top to the bottom of the 
calibrated viscosimeter was measured (time measured in seconds; mean of 
triplicate measures). Viscosity (mPa sec) was calculated according to the 
formula: 
η = ρ t κ 
Where: 
κ is the viscosimeter constant (0.004175), t is the mean of the time 
measurements (sec), ρ is the density (mg/µL). 
 
3.5 Extraction of aqueous and lipid fractions of plasma 
and RBC  
Methanol-chloroform (Sigma-Aldrich, Alcobendas, Madrid, Spain) mixture 
(1000 µL) in a ratio of 2:1 (v/v) was added to 200 µL of each matrix sample 
(plasma and RBC). Homogenates were derived by sonication for 15 min, 
after which 400 µL solution of chloroform: distilled water (1:1; v/v) was 
added and mixed thoroughly. The phases were separated (14,000 x g, 20 
min) in a Multifuge 3L-R centrifuge (Thermo, Madrid, Spain). The upper 
aqueous phase was removed and flash-frozen at -196 ºC in liquid nitrogen 
and then lyophilized overnight to remove water and stored at -80 ºC until 
subsequent NMR experiments. The lower phase (lipid fraction) was allowed 
to dry in a fume hood overnight and then stored at -80 ºC.  
 
3.6 Preparation of aqueous and lipid fractions for 1D 1H 
NMR spectroscopy of plasma and RBC  
The dried aqueous plasma and RBC extracts were reconstituted in 600 µL 
of deuterated water (D2O; Eurisotop , Gif-Sur-Yvette, France) buffered in 40 
mM disodium phosphate (Sigma-Aldrich, Steinheim, Germany), 8 mM 
sodium phosphate (Sigma-Aldrich, Steinheim, Germany) and 0.02% of 
sodium azide (Sigma-Aldrich, Steinheim, Germany) containing 1 mM of 
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sodium (3-trimethylsilyl)-2,2,3,3-tetradeuteriopropionate (TSP; Cortecnet, 
Viosins Le Bretonneux, France) as a chemical shift standard. The mixture 
was placed into 5 mm NMR tubes (Cortecnet, Viosins Le Bretonneux, 
France). 
The dried organic extracts of plasma and RBC were reconstituted in 700 µL 
of a 2:1 (v/v) mixture of deuterated chloroform and deuterated methanol 
(CDCl3: CD3OD; Eurisotop, Gif-Sur-Yvette, France) containing 0.01% (v/v) 
of TMS (Cortecnet, Viosins Le Bretonneux, France) as a chemical shift 
standard, and placed into 5 mm NMR tubes. The NMR tubes were 
maintained at 4 ºC in the sample changer until the time of analysis. 
 
3.7 1D and 2D 1H NMR spectroscopy of plasma and RBC  
All one- and two-dimensional 1H NMR spectra were obtained on a Bruker 
Avance III 600 spectrometer operating at a proton frequency of 600.20 
MHz (14.1 T) equipped with a 10 A GREAT 1/10 gradient amplifier unit 
using a 5-mm CP-TCI triple resonance (1H, 13C, 31P) pulse field gradient 
cryoprobe® (Bruker, Cerdanyola del Vallès, Spain). 
 
3.7.1 1D 1H NMR spectroscopy  
For the one-dimensional (1D) aqueous extract spectra of plasma or RBC, 
1D Nuclear Overhauser Effect Spectroscopy (noesygppr1d Bruker pulse®, 
RD-90º–τ1–90º–τm–90º ACQ) was measured at 300 K. Solvent pre-
saturation with low irradiation power (15 Hz) was applied during recycling 
delay and mixing time (τm =100 ms) to suppress residual water. The 90° 
pulse length was calibrated for each sample and ranged from 8.77 ms to 
9.22 ms. A total of 256 transients were collected across 12 kHz spectral 
width (20 ppm) into 64 k data points, and exponential line broadening of 0.3 
Hz was applied before Fourier transformation. A recycling delay time of 5 s 
was applied between scans to ensure correct quantification. 
In the case of lipid extracts, a 90º pulse with a pre-saturation sequence 
(zgpr Bruker pulse) was used. We performed measurements at 287 K, 
shifting the residual water signal to 4.65 ppm to allow for the quantification 
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of the characteristic glycerol-backbone signals. In addition, residual water 
was pre-saturated during recycling delay (RD= 5 s) using a low irradiation 
power (10 Hz). The 90° pulse length was calibrated for each sample and 
varied from 7.30 ms to 7.59 ms. A total of 256 free induction decays (FIDs) 
of 12 kHz  of spectral width (20 ppm) were collected into 64 k data points, 
and exponential line broadening of 0.3 Hz was applied before Fourier 
transformation. 
All the frequency spectra were phased, baseline corrected and then 
calibrated (TMS or TSP, 0.0 ppm) using TopSpin software (version 2.1, 
Bruker, Germany). Spectra were segmented into 0.03 ppm chemical shift 
bins between 0.2 and 9.6 ppm (excluding water and TSP resonances) 
using a bucket size of 0.03 ppm and the Intelligent Bucketing facility within 
ACD 1D NMR Manager software (version 12; Berks, England). To account 
for differences in sample volumes, each integrated region was normalized 
to the total spectral area for all integral regions in that spectrum, excluding 
water and TSP resonances. Spectra were assigned by comparison with 
assignment of Chenomx NMR Suite version 7.0 (Chenomx; Alberta, 
Canada) for target profiling analysis to determine the metabolites 
contributing to each bin. 
 
3.7.2 2D 1H NMR spectroscopy   
2D diffusion-edited 1H NMR measurements were carried out according to 
Mallol et al. 2011 (Mallol R et al., 2011). Plasma samples (430 µL) from 
sodium citrate and lithium heparin tubes were transferred to 5-mm NMR 
tubes with a double tube system. An internal reference tube (optical 
density; OD 2 mm, supported by a Teflon adapter) containing 9.9 mmol/L 
TSP (reference substance) and 0.47 mmol/L MnSO4 in 99.9% D2O was 
placed coaxially into the NMR sample tube (OD 5 mm). This double tube 
system was kept at 4º C in the sample changer until the moment of 
analysis. 
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1H NMR spectra of plasma were recorded at 310 K to obtain a full signal 
from the mobile lipids in the lipoproteins and to avoid plasma degradation 
during the measurement. 
For diffusion measurements of lipoproteins in plasma, the double-
stimulated echo (DSTE) pulse program was used, with bipolar gradient 
pulses and a longitudinal eddy-current delay (LED; dstebpgp3s Bruker 
pulse sequence). A spectral window of 18028.846 Hz was used, with an 
acquisition time of 1.82 s. During the experiment, the relaxation delay was 
2 s, the FIDs were collected into 64K complex data points, and 32 scans 
were acquired for each sample. The gradient pulse strength was increased 
from 5% to 95% of the maximum strength of 53.5 G cm-1 (0.535 T m-1) in 32 
steps. A diffusion time of 120 ms and bipolar half-sine-shaped gradient 
pulses of 6 ms were applied. All spectra were Fourier transformed, phase 
corrected, baseline corrected, and referenced to the glucose signal at 
5.233 ppm. Diffusion coefficients were obtained using a surface fitting 
approach, as described previously (Mallol R et al., 2011). 
Once the diffusion coefficients have been estimated, the Stokes–Einstein 
equation can be applied to derive the radius associated with each function: 
 
                                                  κ T 
                                     D =  




k (J K-1) is the Boltzmann constant 1.38 10 -23, T (K) is the temperature, η 
(Pa s) is the plasma viscosity (measured on plasma aliquots from sodium 





UNIVERSITAT ROVIRA I VIRGILI 
EFFECT OF FOOD EXTRACTS AND BIOACTIVE FOOD COMPOUNDS ON THE MECHANISM OF ATHEROSCLEROSIS 
AND NUTRITIONAL BIOMARKERS 
Úrsula Catalán Santos 
Dipòsit Legal: T. 1058-2012 
  
 




3.8 FA profile in plasma and RBC by GC-MS  
The D2O lipid aliquots (700 µL) from plasma and RBC samples used for 1D 
1H NMR spectroscopy were evaporated to dryness in the sterile air-flow 
fume hood overnight and then derivatized. Dried samples were dissolved in 
750 µL chloroform/methanol 1:1 (v/v), vortex mixed for 30 s, sonicated for 
10 min followed by the addition of 100 µL D27-tetradecanoic acid (200 µM in 
chloroform; Sigma-Aldrich, Madrid, Spain) as IS. 125 µL of 10% boron 
trifluoride/methanol (Sigma-Aldrich, Madrid, Spain) was added and the vials 
were incubated at 80 ºC for 90 min. On cooling, 500 µL of distillated water 
and 1000 µL hexane (Sigma-Aldrich, Madrid, Spain) were added and 
vortex mixed for 1 min. Two layers were formed and the aqueous top layer 
was aspirated and discarded. The lipid layer was evaporated to dryness in 
the fume hood overnight and 500 µL of hexane was added to the dried 
samples before GC-MS analysis. Food Industry FAME Mix from Restek 
(Teknokroma, Barcelona, Spain) was used for the quantification of the fatty 
acid methyl ester (FAME) from plasma and RBC. 
A 6890 gas chromatograph coupled to a 5973 mass spectrometer (Agilent 
Technologies, Palo Alto, U.S.A.) was used for the FA separation and 
detection, with a FFAP capillary column with dimensions of 30 m x 0.25 
mm x 0.25 µm (Agilent Technologies, Palo Alto, U.S.A.). Helium gas 
(99.999% pure) was used as the carrier at a constant flow of 1.2 mL/min. A 
sample volume of 2 µL was injected in split mode, with a split ratio of 10:1. 
The inlet temperature was of 250 ºC. GC oven temperature program was 
as follows: 60 ºC held for 2 min, then increased at 6 ºC/min to a final 
temperature of 240 ºC which was held for 13 min. Total run time per 
sample was 45 min. Transfer line temperature was of 280 ºC. Source and 
quadrupole temperatures were set at 230 ºC and 150 ºC, respectively, 
while the electron impact source was set at a voltage of 70 MeV. The mass 
spectrometer acquired data in scan mode over a 50 to 650 m/z interval, 
after 2.1 min solvent delay. The compounds were quantified using a target 
ion and identified using qualifier ions and retention times. The 
chromatographic method was calibrated daily by analyzing standard 
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solutions at a range of concentrations from 3 to 120 mg/L of FAMEs, which 
were prepared and analyzed under the same conditions as the plasma and 
RBC samples. The calibration curves obtained by plotting analyte/IS peak 
abundance ratio and the corresponding analyte/IS concentration ratio 
showed good linearity; determination coefficients (r2) being higher than 
0.999 for all compounds.  
Sensitivity was evaluated by determining the limit of detection (LOD), 
(S/N=3) and the limit of quantification (LOQ) which was defined as 5 times 
the LOD. Method detection and quantification limits (MDL and MQL, 
respectively) were calculated for the analysis of 200 µL of sample, following 
the procedures described, above. Values showed MDL in a range from 
0.02 to 1.6 mg/L, while those for MQL were from 0.08 to 8.7 mg/L. Good 
method precision was observed for all the compounds, with relative 
standard deviations (RSD) between 1.2 and 8.3 (n=3). 
 
3.9 Micro-elution solid-phase extraction ( µ-SPE) of 
polyphenols from plasma and RBC  
Polyphenols in the defrosted fasting human plasma and RBC (from sodium 
citrate and lithium heparin samples) were extracted with solid-phase 
extraction using micro-plates as the device format (µ-SPE). Briefly, 400 µL 
of plasma and/or RBC were vortex mixed and centrifuged (2,000 x g, 7 min, 
4 ºC) to sediment cellular debris. From plasma or RBC samples, 350 µL of 
supernatant were recovered and to which 50 µL of IS (Catechol; Sigma-
Aldrich, St. Louis, MO, USA) + 300 µL of 4% phosphoric acid (H3PO4; 
Panreac, Barcelona, Spain) were add to each sample and vortex mixed. 
Because of the matrix consistency of RBC, 500 µL H3PO4 was added and 
the cells ruptured using an S-150D Digital Sonifier® cell disruptor (Branson, 
Ultrasonidos, S.A.E., Barcelona, Spain). Then, a 1:7 mixture (RBC : H3PO4) 
was used as a final volume before performing the corresponding 
polyphenol extraction. Micro-elution plates (Waters, Milford, USA) were 
packed with 2 mg OASIS HLB sorbent (Waters). The cartridges were 
initially conditioned using 250 µL methanol and 250 µL of acidified Milli-Q 
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water at pH 2 in sequence, after which the plasma and RBC samples were 
loaded.  
The plates were “cleaned-up” with sequential 100 µL milliQ water and 100 
µL 5% methanol to eliminate any residual interference/contamination in the 
sample. Finally, polyphenol compounds retained on the column were eluted 
with 100 µL methanol and injected directly into the UPLC–MS/MS. 
 
3.10 UPLC-MS/MS detection of polyphenols from plasma 
and RBC  
The UPLC system consisted of an AcQuity UPLCTM equipped with a binary 
pump system (Waters; Milford, MA, USA) using an AcQuity UPLCTM BEH 
C18 column (1.7 µm, 100 mm × 2.1 mm internal diameter). During the 
analysis, the column was kept at 30 ºC and the flow rate was 0.4 mL/min 
using 0.2% acetic acid as solvent A and acetonitrile as solvent B. The 
elution commenced with 5% eluent B for 5 min, then linearly increased to 
40% eluent B for 20 min, further increased to 100% eluent B for 0.1 min, 
and kept isocratic for 1.9 min, then back to initial conditions in 0.1 min, and 
the re-equilibration for 1.9 min.  
The UPLC system was coupled to a PDA detector AcQuity UPLCTM and a 
TQDTM mass spectrometer (Waters, Milford, MA, USA). The software used 
was MassLynx 4.1. Ionization was by electrospray (ESI) in negative mode 
and then in positive mode. 
The analyses were conducted in full-scan mode in order to determine 
molecular weight. This was followed by daughter scan mode and in 
selected reaction monitoring (SRM) mode to evaluate the fragments 
generated. Ionization source parameters were capillary voltage of 3.0 kV, 
source temperature of 150 ºC, and desolvation gas temperature of 400 ºC 
with a flow rate of 800 L/h. Nitrogen (99% purity, N2 LCMS nitrogen 
generator; Claind, Como, Italy) and argon (≥99.99% purity, Aphagaz, 
Madrid, Spain) were used as the cone and collision gases, respectively.  
The SRM transitions and the individual cone voltage and collision energy 
for each of the standard phenolic compounds were evaluated by infusing 
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10 mg/L of each compound to obtain the best instrumentation conditions. In 
the daughter ion scan experiments, tandem mass spectrometry (MS/MS) 
was used, and the product ions were produced by collision-induced 
fragmentation of selected precursor ions in the collision cell of the triple 
quadrupole mass spectrometer (MS). The mass was then analyzed with 
the instrument’s second analyzer.  
The standard phenolic compounds 3-hydroxyphenylpropionic acid, o-, m- 
and p-hydroxyphenylacetic acid, hydroxybenzoic acid phenylacetic acid 
and hydroxyflavanone were purchased from Sigma-Aldrich (Madrid, Spain). 
Table 2 shows the SRM transitions, cone voltage and collision energy for 
different commercial phenolic compounds. Two transitions were selected 
for quantification and confirmation purposes. 
Table 2. SRM transitions, cone voltage and collision energy for the analysis of phenolic compounds.
2040239 > 931540239 > 1194-Hydroxyflavone 
---520135 > 91Phenylacetic acid
---1520137 > 93p-hydroxybenzoic acid
---1020151 > 107
o-, m- and p-
hydroxyphenylacetic
acid
















3.11 Statistical analysis  
Data were expressed as the mean and SD (error bars). F test was used to 
determine the normality of variances of the two sample types followed by 
the two-tailed t-test, assuming equal variances. The t-test for related 
samples was used to compare differences between sodium citrate and 
lithium heparin samples. The data were analyzed with the SPSS software 
(version 19.0). A value of P<0.05 was considered statistically significant. 
Since multivariate data analysis plays an essential role in evaluating 
differences between metabolomes, thus enabling the identification of 
metabolites relevant to a specific phenotypic characteristic (Koek MM et al., 
2011), we applied multivariate analyses using SIMCA-P + 12.0 software 
(Umetrics AB, Umea, Sweden) with the data having been mean-centered 
UNIVERSITAT ROVIRA I VIRGILI 
EFFECT OF FOOD EXTRACTS AND BIOACTIVE FOOD COMPOUNDS ON THE MECHANISM OF ATHEROSCLEROSIS 
AND NUTRITIONAL BIOMARKERS 
Úrsula Catalán Santos 
Dipòsit Legal: T. 1058-2012 
  
 




and Pareto-scaled prior to analysis. Pareto scaling augments the 
representation of low concentration metabolites in statistical models by 
dividing each integral region, or variable, by the square root of the standard 
deviation of the variable, without increasing the contribution of spectral 
noise to the model. Unit variance (UV) scaling ensures all metabolites 
identified contribute equally to the multivariate dataset. 
Three different multivariate statistical techniques were used within the 
SIMCA package: principal components analysis (PCA); projection to latent 
structures by partial least squares discriminant analysis (PLS-DA); and 
Orthogonal PLS-DA (OPLS-DA). PCA is an unsupervised technique that 
describes observations (e.g. spectra from plasma or from RBC) in relation 
to one or more latent variables, termed principal components (PCs) which, 
in turn, are linear combinations of the original variables (e.g. NMR buckets). 
PLS-DA and OPLS are supervised techniques separating observations 
based on class-membership. In OPLS-DA, the objective is to remove the 
variation in the model that is orthogonal to response. This can more easily 
produce interpretable models where the 1st component represents the 
major changes that distinguish the two groups. The p-value was calculated 
using a Student’s t-test on the coefficients to calculate the contribution to a 
given component made by each variable. 
 
3.11.1 Model validation  
The parameters R2 and Q2 were used to evaluate the performance of each 
model. The R2 score indicates how much of the total variation in the dataset 
is described by a particular component and Rcum
2 indicates the variation 
described by all the components in the model (scored 0-1). Q2 is a measure 
of how accurately the model can predict class membership and, hence, is 
more relevant to supervised approaches. Q2 estimates the predictive ability 
of the model by leaving out observations from the model building, and then 
predicting their class membership or trend variable. Q2 >0.08 is indicative 
of a model that is better than chance, while scores above 0.7 demonstrate 
a highly robust trend, or separation. The validity and the degree-of-fit for 
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Figure 27. Graphical abstract from  study 3 . Biomarkers of Food Intake and Metabolite 
Differences between Plasma and Red Blood Cell Matrices; a Human Metabolomic Profile 
Approach. 
the models were assessed by the criteria and validation routines built into 
the SIMCA package.  
 
Figure 27 represents a graphical description of the design and 
methodology used in the study 3. 
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1. Inhibition of the Transcription factor c-Jun by the 
MAPK family, and not the NF- κB Pathway, Suggests that 
Peanut Extract has Anti-inflammatory Properties ( Study 1 ) 
 
1.1 Cytotoxicity measurements  
Cytotoxicity assay of the peanut extract (5, 25, 50 and 100 µg/mL), 
measured as the activity of LDH release showed no difference compared to 
the LPS treatment alone, confirming that the peanut extract is not cytotoxic 
at the concentrations tested. No cytotoxicity was detected for LPS and BAY 
(data not shown). 
 
1.2 Effect of peanut extract on NF- κB 
The p65-NF-κB activation showed that LPS increased the activity 8-fold 
compared to vehicle control (3.75% DMSO) demonstrating a good 
stimulation of the cells (P<0.05). BAY, used as experimental control, 
decreased the stimulation 4-fold (P<0.05). Peanut extract at the 
concentrations tested (5, 25 and 100 µg/mL) showed no significant 
difference in p65-NF-κB activation compared to LPS alone (Figure 28 ). 
 
1.3 Effect of peanut extract on MAPK family  
The transcription factors ATF-2, c-Myc, STAT1 and MEF2 did not show any 
significant differences at any peanut extract concentration tested (5, 25 and 
100 µM). However BAY (5 µM) reduced MEF2 compared to LPS, albeit 
non-significantly. c-Jun transcription factor was reduced by BAY (5 µM) by 
86% and peanut extract (25 and 100 µM) by 54% and 93%, respectively 
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Figure 28. Effect of peanut extract on NF -κB. THP-1 monocytes were incubated with vehicle 
control (3.75% DMSO), BAY 11-7082 (5µM) and peanut extract (5, 25 and 100 µg/mL) for 1h and 
stimulated with LPS (500 ng/mL) for 1h. NF-κB binding was measured using an ELISA kit 
(TransAM®). Data are expressed as percentage LPS values of two separate experiments run in 
triplicate. Error bars show SD. *P<0.05 versus LPS. 
 
Figure 29. Effect of peanut extract on c -Jun. THP-1 monocytes were incubated with vehicle 
control (3.75% DMSO), BAY 11-7082 (5µM) and peanut extract (5, 25 and 100 µg/mL) for 1h and 
stimulated with LPS (500 ng/mL) for 1h. c-Jun binding was measured using an ELISA kit 
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Figure 30. Effect of peanut extract on TNF -α mRNA in THP -1 cell s using RT -PCR assay.  THP-
1 monocytes were incubated with vehicle control (3.75% DMSO), BAY 11-7082 (5µM) and peanut 
extract (5, 25, 50 and 100 µg/mL) for 1h and stimulated with LPS (500 ng/mL) for 4h. The 
abundance of mRNA transcripts for TNF-α was determined using real time quantitative polymerase 
chain reaction (RT-PCR). Data were normalized using the values obtained for GAPDH (house 
keeping gene), and are the mean of two separate experiments run in triplicate. Error bars show SD. 
*P<0.05 versus LPS. 
1.4 Effect of peanut extract on TNF- α mRNA in THP-1 cells 
usint RT-PCR assay  
LPS (500 ng/mL) stimulated TNF-α mRNA production 7-fold compared to 
vehicle control (3.75% DMSO) in THP-1 (P<0.05). BAY (5 µM) decreased 
LPS (500 ng/mL) stimulation 2-fold (P<0.05). 
TNF-α mRNA expression at all concentrations tested (5, 25, 50 and 100 
µg/mL) showed reductions albeit statistically non-significant, of 9 %, 24 %, 
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Figure 31 . Effect of peanut extract on TNF -α mRNA stabilization in THP -1 cells using RT -PCR 
assay.  THP-1 monocytes were incubated with vehicle control (3.75% DMSO), BAY 11-7082 (5 µM) 
and peanut extract (50 µg/mL) for 1h and stimulated with LPS (500 ng/mL) for 2h. After 2h of 
incubation of LPS, Act D 5µg/mL was added to medium. The incubation times with Act D were 30, 
60, 120 and 180 min. At these times the cells were lysed to obtain total RNA. The abundance of 
mRNA transcripts for TNF-α was determined using real time quantitative polymerase chain reaction 
(RT-PCR). Data were normalized using the values obtained from GAPDH (house keeping gene), 
and are the mean of two separate experiments run in triplicate. Error bars show SD. *P<0.05 versus 
vehicle control. 
 
1.5 Effect of peanut extract on TNF- α mRNA stability in 
THP-1 cells usint RT-PCR assay  
Under vehicle control condition (3.75% DMSO), TNF-α mRNA levels fell 
significantly (P<0.05) relative to the starting point (time 0 min) of the kinetic 
measurements. The decline under the other test conditions (LPS, BAY and 
peanut extract) was progressive over the first 30 min, compared time 0 min. 
At 30 min LPS, BAY and peanut extract decreased to the minimum TNF-α 
mRNA level as that measured in the vehicle control. There were no 
significant differences between LPS, BAY and peanut extract compared to 
vehicle control at any of the time points i.e. peanut extract did not stabilize 
TNF-α mRNA (Figure 31). 
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Figure 32. Effect of peanut extract on TNF -α protein secretion.  THP-1 monocytes were 
incubated with vehicle control (3.75% DMSO), BAY 11-7082 (5µM) and peanut extract (5, 25, 50 
and 100 µg/mL) for 1h and stimulated with LPS (500 ng/mL) for 4h. TNF-α protein secretion was 
determined by ELISA. Data are the mean of two separate experiments run in triplicate. Error bars 
show SD. (A) Extracellular TNF-α protein secretion. *P<0.05 versus LPS; (B) intracellular TNF-α 
protein secretion; (C) total TNF-α protein secretion. *P<0.05 versus LPS 
 
1.6 Effect of peanut extract on TNF- α protein  
In monocyte THP-1 cells, maximum stimulation of TNF-α at LPS 
concentration of 500 ng/mL and 4h incubation in the absence of peanut 
extract revealed that approximately 85% of the TNF-α release was 
extracellular, while 15% remained inside the cell (Figure 32A and B). The 
results for extra-, intracellular, and total TNF-α release in THP-1 cells pre-
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1.6.1 Extracellular TNF- α protein 
BAY (5 µM) decreased LPS-stimulated (500 ng/mL) extracellular TNF-α 
protein nearly 3-fold (P<0.05).  
Peanut extract inhibited the secretion of extracellular TNF-α protein 
secretion by 18% and 29% at 25 and 50 µg/mL, respectively; but only 47% 
of extracellular TNF-α protein reduction at 100 µg/mL was statistically 
significant (P<0.05) compared with LPS alone (Figure 32A ).  
 
1.6.2 Intracellular TNF- α protein 
The concentration of the remaining intracellular TNF-α protein was very low 
compared to he extracellular component (Figure 32B ), suggesting that 
most of the TNF-α protein was secreted to the extracellular medium when 
cells are incubated for 1h with the peanut extract following 4h stimulation 
by LPS (500 ng/mL). 
 
1.6.3 Total TNF-α protein 
Peanut extract concentrations (5, 25, 50 and 100 µg/mL) induced a 
decrease in total TNF-α protein secretion; the reductions were 15%, 23% 
and 30% at 25, 50 and 100 µg/mL respectively albeit the reductions were 
not statistically significant (Figure 32C ). The results of total TNF-α protein 
secretion are similar to that observed with extracellular TNF-α protein.  
BAY (5 µM) decreased 3-fold the total TNF-α protein concentration induced 
by LPS (500 ng/mL) stimulation (P<0.05).  
The same tendency was observed for peanut extract on TNF-α mRNA 
(Figure 30 ) and on total and extracellular TNF-α protein secretion (Figure 
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Figure 33. Effect of peanut extract on TACE activity.  THP-1 monocytes incubated with vehicle 
control (3.75% DMSO), BAY 11-7082 (5µM) and peanut extract (5, 25, 50 and 100 µg/mL) for 1h 
and stimulated with LPS (500 ng/mL) for 4h. TACE activity was determined by a fluorimetric assay 
(see text for details). Data are the mean of two separate experiments run in triplicate. Error bars 
show SD. *P<0.05 versus LPS 
 
1.7 Effect of peanut extract on TACE activity  
Basal TACE activity in THP-1 cells was detectable under all cell conditions 
tested. BAY (5 µM) significantly (P<0.05) reduced the basal activity of 
TACE, while peanut extract (5, 25, 50 and 100 µg/mL) did not modify the 
TACE basal activity. 
TACE activity was not sensitive to LPS (500 ng/mL), indicating a failure of 
LPS to stimulate any TACE catalytic activity response in THP-1 cells 
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Figure 34. Cytotoxicity from HAEC incubated with AT or BAY and stimulated with TNF -α. (A) 
Activity of LDH released into the cell-culture supernatants of HAEC following incubation with AT (10, 
25, 50, 75 and 150 µM) for 6h. (B) Activity of LDH released into the cell-culture supernatants of 
HAEC following stimulation with TNF-α (10 ng/mL) in the presence (1µM) for 24h or absence of 
BAY. Vehicle control refers to cells incubated with AT vehicle (absolute ethanol). Blank control 
refers to cells incubated without ethanol, TNF-α, BAY or AT. Results are the mean and the SD (error 
bars) of optical density (OD) from one representative experiment where each set of experimental 
conditions was run in triplicate.  
2. Alpha-Tocopherol and BAY 11-7082 Reduce Vascular 
Cell Adhesion Molecule in Human Aortic Endothelial Cells  
(Study 2 ) 
 
2.1 Cytotoxicity  
There was no evidence of HAEC cytotoxicity following exposure to AT (10, 
25, 50, 75 and 150 µM) for 6h (Figure 34A ) nor TNF-α (10 ng/mL; Figure 
34B) for the subsequent 24h. No cytotoxicity was observed, as assessed 
by LDH activity release, at the concentrations of BAY tested (1 µM) under 
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2.2 Effect of AT and BAY on CAMs mRNA expression by 
HAEC stimulated with TNF- α 
Exposure of cells to TNF-α (1 ng/mL for VCAM-1; 10 ng/mL for E-selectin 
and ICAM-1) for 24h induced strong up-regulation of CAMs mRNA 
expression (Figure 35 ). 
As shown in Figure 35A , AT (at 50, 75 and 150 µM) significantly reduced 
VCAM-1 mRNA expression in TNF-α-stimulated HAEC by approximately 
37% (P<0.05). The intra-assay CV was <20%, the inter-assay CV was 
<21%. Compared to TNF-α alone, BAY treatment (0.1 µM) significantly 
blocked TNF-α-induced VCAM-1 mRNA expression by approximately 25% 
(P<0.05) (Figure 35A ). The intra- and inter-assay CVs were <13%. 
 
There was a tendency towards reducing E-selectin mRNA expression by 
AT and BAY by approximately 40% and 25%, respectively, but these 
reductions was not statistically significant (Figure 35B ). 
ICAM-1 mRNA expression was decreased by AT and BAY by 25-40% and 
13%, respectively compared to TNF-α stimulation, but the decrease did not 
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Figure 35. Effect of AT and BAY on CAMs mRNA expression in HAEC stimulated by TNF -α.  
(A) Effect of AT and BAY on VCAM-1 mRNA expression. (B) Effect of AT and BAY on E-selectin 
mRNA expression. (C) Effect of AT and BAY on ICAM-1 mRNA expression. Results are the mean 
and the SD (error bars) of two independent experiments where each set of experimental conditions 
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2.3 Effect of AT and BAY on sCAMs protein secretion by 
HAEC stimulated with TNF- α 
When cells were exposed to TNF-α (10 ng/mL), sVCAM-1, sE-selectin and 
sICAM-1 increased significantly to 7.71 (0.40) ng/mL, 0.33 (0.08) ng/mL 
and 13.31 (0.76) ng/mL, respectively (P<0.05; Figure 36). 
AT significantly reduced sVCAM-1 protein secretion by about 40% in the 
highest doses tested (50, 75 and 150 µM) compared to TNF-α alone (10 
ng/mL) (P<0.05) (Figure 36A ). No dose-response effect was observed. 
The inter- and intra-assay CVs were <12%. AT also reduced sE-selectin 
(between 5 and 29%) and sICAM-1 (between 5 and 16%) at all doses 
tested, but the decreases did not reach statistical significance. 
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Figure 36. Effect of AT and BAY on sCAMs protein secretion in HAEC stimulated by TNF -α.  
(A) Effect of AT and BAY on sVCAM-1 protein release. (B) Effect of AT and BAY on sE-selectin 
protein release. (C) Effect of AT and BAY on sICAM-1 protein release. Results are the mean and 
the SD (error bars) of two independent experiments where each set of experimental conditions was 
run in triplicate. *p< 0.05 versus TNF-α-alone. 
 
BAY (1µM) reduced TNF-α (10 ng/mL) effects on sVCAM-1, sE-selectin 
and sICAM-1 release by 53%, 50% and 26%. Only the effects on sVCAM 
and sE-selectin were statistically significant (P<0.05) (Figure 36A , B and 
C). 
As shown in Figure 36B and C, non-activated HAEC did not appear to 
release sE-selectin (limit of detection <0.125ng/mL) and sICAM-1 (limit of 
detection <1.56 ng/mL), but the non-activated cells did express sVCAM-1 
(2.12 ng/mL; Figure 36A ). Treatment of HAEC with AT had no statistically 
significant reduction effect on sE-selectin (between 5 and 29% reduction) 
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2.4 Effect of AT and BAY on lymphocyte cell adhesion to 
HAEC 
Qualitatively (Figure 37 ), there appeared to be a considerable number of 
Jurkat-T-cells adhering to TNF-α-treated HAEC, while very few cells 
adhered to untreated HAEC. Adhesion to HAEC that had been incubated 
with BAY (0.5, 1, 2 and 5 µM) appeared to be greatly decreased. Adhesion 
to HAEC that had been pre-incubated with AT (10, 25, 50, 75 and 150 µM) 
for 6h appeared to decrease the adhesion of HAEC to Jurkat-T-cells at all 
concentrations tested (Figure 37). 
The cell fluorescence images revealed that exposure of cells to TNF-α (10 
ng/mL) for 24h induced strong adhesion between Jurkat-T-cells and HAEC 
(Figure 38). The effects of different concentrations of AT and B AY on TNF-
α-induced cell surface adhesion molecules expression are depicted in 
(Figure 38). AT failed to modulate significantly the TNF- α-induced cell 
surface expression of CAMs at any of the concentrations (a reduction of 
between 11 and 17%) (Figure 38). In contrast, when treated with BAY (0.1, 
1, 2 and 5 µM), the TNF-α-induced cell surface expression of CAMs was 
notably reduced to 7%, 13%, 57% and 77%, respectively; statistically 
significant reductions being observed only at 2 and 5 µM (P<0.05). 
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Figure 37. Adhesion of Jurkat -T-cells to TNF -α-treated HAEC  images under microscope (x4) . 
Microscope images of the experiments. Conditions used for this study were: Vehicle control; TNF-α 
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Figure 38. Adhesion of J urkat -T-cells to TNF -α-treated HAEC . Effect of AT, at all concentrations 
tested (10, 25, 50, 75 and 150 µM) on cell-cell adhesion. Data are the mean and the SD (error bars) 
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3. Biomarkers of Food Intake and Metabolite Differences 
between Plasma and Red Blood Cell Matrices; a Human 
Metabolomic Profile Approach ( Study 3 ) 
 
3.1 Biochemical parameters  
Table 3 summarizes the characteristics of the 10 healthy male volunteers. 
The mean (SD) age was 44 (11.5) years. Of these individuals, 40% were 
within the reference range with respect to cholesterol concentrations 
(reference range: 3.1 - 5.15 mmol/L); 50% with respect to apolipoprotein 
B100 (reference range: 70 - 105 mg/dL); 70% with respect to HDL-c 
(reference value: >1.30 mmol/L) and creatinine (reference range: 0.6 - 1.30 
mg/dL); 80% with respect to bilirubin (reference value: <1.1 mg/dL). With 
respect to the rest of the parameters studied, between 90-100% of the 
participants were within the reference ranges. 
9098 - 279130.30 (29.91)Alkaline phosphatase; U/L
10011 - 5021.00 (9.67)Gamma glutamyl transferase; U/L
9010 - 4121.20 (9.63)Glutamil pyruvic transaminase; U/L
90< 3824.90 (9.71)Glutamic oxaloacetic transaminase; U/L
9015 - 4533.70 (8.47)Urea; mg/dL
700.6 - 1.300.66 (0.17)Creatinine; mg/dL
80< 1.10.84 (0.22)Bilirubin; mg/dL
1003.6 - 7.75.15 (0.90)Uric acid; mg/dL
9059.4 - 109.899.80 (10.28)Glucose; mg/dL
5070 - 10596.60 (17.39)Apolipoprotein B100; mg/dL
100122 - 161136.20 (6.79)Apolipoprotein A1; mg/dL
70> 1.301.41 (0.15)HDL; mmol/L
1000.45 - 1.860.93 (0.37)Triglycerides; mmol/L
403.1 - 5.155.08 (0.69)Cholesterol; mmol/L




Absolute values mean SD
Men (N = 10)
Measured parameter
Table 3. Basal biochemical values, reference ranges, and percentages of basal values within the reference range.
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Figure 39 . Series of PCA models to examine the differences in plasma and RBC matric es 
derived from blood collected with sodium citrate or lithium heparin as anticoagulants.  (A.1) 
PCA scores plot of aqueous fraction from plasma using sodium citrate (▲) compared with the same 
fraction using lithium heparin (■) (R2 = 94%, Q2 = 87.7%). (A.2) PCA scores plot of lipid fraction from 
plasma using sodium citrate (*) compared with the same fraction using lithium heparin (+) (R2 = 
87.9%, Q2 = 73%). (B.1) PCA scores plot of aqueous fraction from RBC using sodium citrate (♦) 
compared with the same fraction using lithium heparin (●) (R2 = 72.2%, Q2 = 48.1%). (B.2) PCA 
scores plot of lipid fraction from RBC using sodium citrate (○) compared with the same fraction using 
lithium heparin (▬) (R2 = 97.9%, Q2 = 92.2%). 
 
3.2 Sodium citrate and lithium heparin samples  
With respect to sodium citrate compared with lithium heparin samples, 
there were no significant differences in the lipid fraction in relation to the 
anticoagulant used (Figure 39, A.2 and B.2 respectively). Concerning the 
non-lipid (aqueous) fraction, the sodium citrate plasma samples had a 
higher concentration of citrate compared to the lithium heparin samples 
(Figure 39, A.1 ) while, conversely, RBC showed no significant differences 
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Figure 40 . A typical 500 -MHz 1H NMR spectrum of aqueous fraction from human plasma and 
RBC. (A) Representative spectrum of aqueous fraction from plasma sample (lithium heparin). (B) 
Representative spectrum of aqueous fraction from RBC sample (lithium heparin). The major 
aqueous metabolites identified are: 1: valine, leucine and isoleucine; 2: lactate; 3: alanine; 4: lysine; 
5: acetate; 6: acetone; 7: acetoacetate; 8: glutamine; 9: citrate; 10: creatine; 11: glucose and amino 
acids; 12: β-glucose; 13: α-glucose; 14: tyrosine; 15: histidine; 16: phenylalanine; 17: pyridoxine; 18: 
hydroxibenzoate; 19: ADP-ATP 
3.3 Aqueous metabolites comparison between plasma and 
RBC 
The aqueous metabolites in plasma and in RBC matrix were identified as: 
1) valine, leucine and isoleucine; 2) lactate; 3) alanine; 4) lysine; 5) acetate; 
6) acetone; 7) acetoacetate; 8) glutamine; 9) citrate; 10) creatine; 11) 
glucose and amino acids; 12) β-glucose; 13) α-glucose; 14) tyrosine; 15) 
histidine; 16) phenylalanine; 17) pyridoxine; 18) hydroxibenzoate; 19) ADP-
ATP. Comparing the aqueous fraction from both matrices (plasma vs. 
RBC), 1D 1H NMR showed higher concentrations of glucose in plasma than 
RBC and less ADP-ATP and creatine (R2=67.2%, Q2=80.3%) (Figure 40 ). 
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Figure 41 . A typical 500 -MHz 1H NMR spectrum of organic fraction from human plasma and 
RBC. (A) Representative spectrum of organic fraction from plasma sample (lithium heparin). (B) 
Representative spectrum of organic fraction from RBC sample (lithium heparin). The major organic 
metabolites identified are: 1: cholesterol; 2: lipoproteins; 3: phosphatidyl ethanolamine; 4: 
phosphatidyl choline; 5: triglycerides; 6: phosphatidyl serine, ethanolamine and choline; 7: 
sphingomyelin; 8: plasmalogen 
 
3.4 Lipoprotein measurements  
1D 1H NMR spectroscopy analysis showed that measurable lipoprotein 
content was higher in plasma samples than in RBC (R2 = 70.6%, Q2 = 
94.6%) in which the following organic metabolites were found: 1) 
cholesterol; 2) lipoproteins; 3) phosphatidyl ethanolamine; 4) phosphatidyl 
choline; 5) triglycerides; 6) phosphatidyl serine, ethanolamine and choline; 
7) sphingomyelin; 8) plasmalogen (Figure 41 ). 
 

































2D diffusion-edited 1H NMR spectra and its corresponding functions (F1-
F7) from a representative plasma sample are shown in Figure 42A . 
Spectra recorded at low gradient strengths (<13%) were not used in order 
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Figure 42 . (A) Example of 2D diffusion-edited 1H NMR global spectra and optimal functions used to 
fit the surface. (B) Spectrum from total plasma obtained using sodium citrate and lithium heparin as 
anticoagulants. 
to avoid interferences from low molecular weight metabolites. A 
representative comparison between plasma obtained from sodium citrate 





Table 4 and 5 summarize the means (SD) of relative areas, diffusion 
coefficients, radii of the lipoprotein subclasses corresponding to plasma 
obtained from both anticoagulants (sodium citrate and lithium heparin). 
Lipoprotein absolute areas, represented as arbitrary units mean (SD) of 
samples from sodium citrate and lithium heparin tubes were: F1 796 488.08 
(16 426.53), P=0.62; F2 715 802.28 (89 997.08), P=0.001); F3 577 744.98 
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(88 059.11), P=0.01; F4 512 310.34 (55 096.58), P=0.13; F5 442 228.58 
(73 839.13), P=0.02; F6 353 005.90 (44 997.73), P=0.01) and F7 187 
808.09 (24 434.51), P=0.41). These values were related to the lipoprotein 
concentrations and, as such, plasma from sodium citrate anticoagulation 
was more diluted than the plasma from lithium heparin anticoagulation; F1 
(2.87%), F2 (16.33%), F3 (19.46%), F4 (14.13%), F5 (21.12%), F6 
(16.54%) and F7 (16.85%); (P<0.05). 
However, when the absolute areas were converted to relative areas (%), 
these differences resulting from type of anticoagulant ceased to be 




















diffusion coefficient (m2/sec)relative areas (%)
Function
Table 4 . Means and standard deviations of relative areas (%) and diffusion coefficient (m2/sec) of lipoprotein subclasses in plasma
Plasma lipoprotein subclasses expressed as the relative areas and diffusion coefficients corresponding to plasma obtained 
from both anticoagulants (sodium citrate and lithium heparin) determined by 2D diffusion-edited 1H NMR spectra and its 
functions (F1-F7). P values indicated differences between blood drawn using sodium citrate and lithium heparin as 
anticoagulants from n=10 healthy individuals.
Lipoprotein absolute areas, represented as arbitrary units mean (SD) of samples from sodium citrate and lithium heparin 
tubes were: F1 796 488.08 (16 426.53), P=0.62; F2 715 802.28 (89 997.08), P=0.001); F3 577 744.98 (88 059.11), P=0.01; 
F4 512 310.34 (55 096.58), P=0.13; F5 442 228.58 (73 839.13), P=0.02; F6 353 005.90 (44 997.73), P=0.01) and F7 187 
808.09 (24 434.51), P=0.41). 
 
 
According to the Stokes-Einstein equation, size and lipoprotein diffusion 
coefficients were related to plasma viscosity; sodium citrate plasma 1.17 
(0.08; mPa sec) vs. 1.25 (0.08; mPa sec) for lithium heparin plasma i.e. 
lipoproteins in sodium citrate plasma diffuse faster than lithium heparin 
plasma (P<0.05). Conversely, the lipoprotein radii measurements showed 
no significant differences between citrate and heparin plasma, due to 
normalization for viscosity. 
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The smallest function (F7) had the highest diffusion coefficient, the smallest 
lipoprotein area and the smallest lipoprotein radius, while the highest 
function (F1) had the smallest diffusion coefficient, the largest lipoprotein 
area and the largest lipoprotein radius. 
The lipoprotein areas and radii were directly related to each other and both 
were inversely related to the diffusion coefficient. 
Lipoprotein subclasses (Table 5)  were defined according to the reference 
lipoprotein subclass radii established by Duell et al (Duell PB, Illingworth, 























Table 5 . Means and standard deviations of radius (Å), reference ranges of lipoprotein subclass radii (Å) and 
lipoprotein subclass conventional terminology
Plasma lipoprotein subclasses expressed as radii corresponding to plasma obtained from both anticoagulants 
(sodium citrate and lithium heparin) determined by 2D diffusion-edited 1H NMR spectra and its functions (F1-F7). P
values indicated differences between blood drawn using sodium citrate and lithium heparin as anticoagulants from 
n=10 healthy individuals; Å = angstrom units = 10-10m
Lipoprotein subclasses radius reference range as described by Duell et al (Duell PB, Illingworth, D. R. and Connor, 
W. E., 2001). 
 
3.5 FA comparison on between plasma and RBC  
Plasma and RBC FA concentrations and percentages are summarized in 
Table 6 . Plasma had more FAMEs than the RBC matrix. 
In RBC, the percentages of the saturated fatty acids (SFA) 16:0, 17:0, 20:0 
and 24:0 and the polyunsaturated fatty acids (PUFA) 22:6 n-3 and 20:4 n-6 
were higher than in plasma (P<0.05). However in plasma, the percentage 
SFA 14:0, monounsaturated fatty acids (MUFA) 14:1 n-5, 16:1 n-7, 17:1 n-
7 and 18:1 n-9 and PUFA 18:3 n-3, 18:2 n-6, 18:3 n-6 and 20:3 n-6 were 
higher than in RBC (P<0.05). 
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0.0026.86 (1.17)11 (0.21)0.21158.66 (5.98)231.75 (56.15)20:4 n-6Arachidonic acid
0.011.62 (0.09)2.35 (0.01)0.039.58 (1.28)49.64 (10.93)20:3 n-6DHGLA
0.250.13 (0.08)0.22 (0.01)0.050.79 (0.54)4.74 (1.17)20:2 n-6Eicosadienoic acid
0.000.00 (0.01)0.41 (0.03)0.040.02 (0.038.74 (2.54)18:3 n-6Gamma-linolenic acid 
<0.00124.37 (0.11)53.13 (0.34)0.03143.92 (12.29)1124.59 (244.45)18:2 n-6Linoleic acid
n-6
0.007.96 (0.14)2.75 (0.25)0.4847.03 (2.97)58.18 (18.23)22:6 n-3DHA
0.990.55 (0.13)0.55 (0.01)0.043.22 (0.49)11.67 (2.47)20:5 n-3EPA
0.030.00 (0.00)0.21 (0.05)0.090.00 (0.00)4.48 (2.00)18:3 n-3ALA
n-3
PUFA
0.550.18 (0.03)0.16 (0.06)0.261.09 (0.11)3.33 (2.03)20:1 n-9Eicosenoic acid
0.019.33 (0.18)10.5 (0.07)0.0455.09 (3.42)222.91 (51.20)18:1 n-9Oleic acid
0.040.01 (0.01)0.08 (0.02)0.100.03 (0.04)1.68 (0.79)17:1 n-7
0.000.15 (0.06)1.43 (0.02)0.030.88 (0.30)30.36 (7.23)16:1 n-7Palmitoleic acid
0.030.00 (0.00)0.02 (0.00)0.090.00 (0.00)0.36 (0.16)14:1 n-5Myristoleic acid
MUFA
0.030.15 (0.04)0.00 (0.00)0.010.90 (0.16)0.00 (0.00)24:0Lignoceric acid
0.530.03 (0.03)0.01 (0.01)0.930.15 (0.22)0.13 (0.19)22:0Behenic acid
<0.0010.14 (0.00)0.04 (0.00)0.950.85 (0.09)0.84 (0.20)20:0Arachidic acid
0.167.44 (0.02)3.95 (0.82)0.2943.93 (15.95)83.56 (35.55)18:0Stearic acid
0.000.74 (0.02)0.37 (0.02)0.074.39 (0.23)7.84 (1.40)17:0Margaric acid
0.0118.55 (0.70)11.2 (1.03)0.03109.59 (4.76)235.93 (31.59)16:0Palmitic acid
0.090.25 (0.00)0.27 (0.01)0.031.47 (0.09)5.81 (1.08)15:0
0.020.58 (0.02)0.79 (0.04)0.023.42 (0.40)16.75 (2.87)14:0Myristic acid
0.430.00 (0.00)0.00 (0.00)0.420.00 (0.00)0.05 (0.06)13:0
0.060.95 (0.05)0.63 (0.10)0.015.60 (0.72)13.40 (0.99)12:0Lauric acid
SFA
PRBCPlasmaPRBCPlasmaFatty AcidFatty acid




Table 6. Fatty acid composition in plasma and red blood cell (RBC) matrices 
P values indicated differences between Plasma and RBC from n=10 healthy individuals.
Abbreviations: FAME, fatty acid methyl ester; n = 20 for plasma and 20 for red blood cell; P < 0.05; ALA: alpha-linolenic acid; EPA: 
eicosapentaenoic acid; DHA: docosahexaenoic acid; DHGLA: dihomo-gamma-linolenic acid  
 
3.6 Plasma and RBC polyphenols  
Plasma and RBC obtained from sodium citrate and lithium heparin samples 
had similar chromatogram traces for the analyses of phenols. Plasma and 
RBC polyphenol peaks are shown in Figure 43 . We were able to identify 
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Figure 43.  A representative UPLC chromatogram (278 nm) obtained from the analysis of (A) 
plasma lithium heparin samples, and (B) RBC lithium heparin samples. 
 
several polyphenols in plasma (Figure 44). These included: 3-
hydroxyphenylpropionic acid (peak 4), o-, m- and p-hydroxyphenylacetic 
acid (peak 6), hydroxybenzoic acid (peak 7), phenylacetic acid (peak 8) 
and hydroxyflavanone (peak 10). Further, unidentifiable peaks in plasma 
were at molecular weight 180 g/mol (peak 1 and 2), 204 g/mol (peak 3), 
194 g/mol (peak 5) and 254 g/mol (peak 9). In RBC, the unidentifiable 
peaks were at molecular weights of 346 g/mol (peak 11), 695 g/mol (peak 
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Figure 44.  A representative UPLC-MS/MS for analysis of (A) plasma lithium heparin samples, and 






Peak 6 Peak 7 
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Inhibition of the Transcription factor c-Jun by the MAPK 
family, and not the NF- κB Pathway, Suggests that Peanut 
Extract has Anti-inflammatory Properties ( Study 1 ) 
The present study confirms our hypothesis that peanut extract (at 100 
µg/mL) exerts an anti-inflammatory effect, in THP-1 monocytes challenged 
with LPS, by reducing the secretion of the biologically active soluble form of 
extracellular TNF-α protein. 
Further, we propose a standardized in vitro monocyte cellular assay (from 
signal transduction to extracellular secretion of TNF-α) which can be used 
to evaluate anti-inflammatory mechanisms of such products such as food 
extracts and synthetic compounds. 
The present study demonstrated that the synthetic compound BAY, used 
as experiment control, can reduce the TNF-α protein secretion by inhibiting, 
specifically, NF-κB transcription factor and the subsequent steps of the 
TNF-α production i.e. via TNF-α mRNA intra- and extracellular and total 
TNF-α protein. However, BAY (5 µM) had no effect on the mRNA stability 
of TNF-α.  
With the MAPK family, we observed an alternative effect of BAY by 
reducing the activities of MEF2 and c-Jun transcription factor. Inhibition of 
c-Jun by BAY has been demonstrated by some investigators such as Lee 
HS et al. (Lee HS et al., 2010). However, to the best of our knowledge, the 
inhibition of MEF2 by BAY has not, until now, been observed. We suggest 
that the reduction of TNF-α produced by BAY is via the inhibition of both 
transcription factor pathways: the NF-κB and the MAPK family. We also 
demonstrated that BAY (5 µM) has the ability to reduce the basal TACE 
activity in THP-1 monocytes which, to the best of our knowledge, has not 
been documented in the literature, to date. Thus, BAY can be used as an 
experiment control for the in vitro THP-1 monocyte model. The model is 
appropriate for detecting anti-inflammatory effects and, as such, may be 
applicable in assessing a range of natural food extracts that are considered 
to have beneficial anti-inflammatory properties. 
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Peanut extract, at all concentrations tested in this study, had no effect on 
NF-κB nuclear transcription factor, compared to LPS alone. Our results 
showed that the mechanism of action of peanut extract is via the inhibition 
of the transcription factor c-Jun from MAPK family. This inhibition of c-Jun 
by peanut extract was significant at 25 and 100 µg/mL concentration. 
Subsequently, we observed that peanut extract slightly decreased (but not 
statistically significantly) TNF-α mRNA. Stabilization of mRNA by peanut 
extract was not observed. Peanut extract (100 µg/mL) induced a reduction 
of the TNF-α soluble active form and extracellular TNF-α protein, and 
exerted a final anti-inflammatory effect at the end of the pathway. The 
intracellular TNF-α protein concentration reflects both the cytoplasmic 
domain and the trans-membrane segment of TNF-α protein. The 
mechanism linking the disruption of the pathway with the extracellular 
region that contains the soluble biological form (Ishisaka R et al., 1999) 
needs to be elucidated further.  
A mechanism that needs to be taken into account is the enzyme that 
produces the soluble TNF-α protein in the culture medium i.e. the TACE 
enzyme. It is a member of the disintegrin and metalloprotease (the ADAM 
family) which cleaves various trans-membrane proteins within their “stalk” 
sequences, releasing (“shedding”) a soluble form including the functional 
extracellular domains (Black RA, 2002). In this study, we showed that LPS 
(500 ng/mL) stimulation alone of THP-1 cells has no effect on TACE 
activity. This suggests that the basal level of TACE activity present in THP-
1 cells may be sufficient for the release of TNF-α from LPS-stimulated cells 
(15% of RFU) or that LPS shedding per se may not be activated in the case 
of LPS-induced TNF-α release (Doedens JR and Black RA, 2000). 
Although some groups of investigators have provided evidence for 
stimulation of TACE mRNA transcription, protein content, and catalytic 
activity by LPS, others have not (Doedens JR et al., 2003; Ermert M et al., 
2003; Armstrong L et al., 2006; Rozenova KA et al., 2010). Our results 
demonstrated that peanut extract, at any of the concentrations tested (5, 
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25, 50 and 100 µg/mL), did not affect TACE activity while, conversely, 
reduction in activity is sensitive to BAY. 
The data from the present study suggest that, in the model of human 
monocytic THP-1 cells stimulated with LPS, extracellular TNF-α protein is 
inhibited by peanut extract.  
The anti-inflammatory model we present in this article could become a gold 
standard since the markers of quality of analysis such as precision (mean 
of 10% and 20% intra- and inter-assay CV, respectively) and accuracy will 
become reference parameters in comparing future models of inflammation. 
As such, the model can be used not only in basic research but also in the 
assessment of additives (food fortification) and other outcomes in the food 
industry. 
 
Alpha-Tocopherol and BAY 11-7082 Reduce Vascular Cell 
Adhesion Molecule in Human Aortic Endothelial Cells  
(Study 2 ) 
Our results indicated that treatment with AT (50, 75 and 150 µM) inhibits 
VCAM-1 mRNA and sVCAM-1 protein by between 36 and 40% in TNF-α-
stimulated HAEC. In contrast, when we analyzed the effects of AT on 
stimulated HAEC, we observed a non-significant decrease in E-selectin 
and ICAM-1 mRNA expression (40% and 25 to 40% respectively) and in 
sE-selectin and sICAM-1 protein release (5 to 29% and 5 to 16%, 
respectively) compared to TNF-α-alone (10 ng/mL). As such, AT appears to 
play a beneficial role in atherosclerosis by specifically reducing VCAM-1, 
but not the other CAMs studied, such as E-selectin and ICAM-1. 
Optimum serum concentration of AT in humans is around 23.2 µM (Gamez 
C et al., 1996), and which is similar to the concentrations selected for our 
investigation. 
We also observed that, in TNF-α stimulated HAEC, BAY (at 0.1 µM) 
reduced VCAM-1 mRNA expression by 25% and sVCAM-1 protein release 
by 53%. Similarly, BAY (at 1 µM) decreased  E-selectin and ICAM-1 mRNA 
expression by 25% and 13%, respectively and sE-selectin and sICAM-1 
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protein release by 50% and 26%, respectively; albeit these reductions were 
not statistically significant. 
VCAM-1 is an important adhesion molecule that is up-regulated during 
endothelial activation by various factors such as TNF-α. Belonging to the 
immunoglobulin superfamily, it has adhesion molecule properties and acts 
as a ligand for activated leukocyte adhesion to endothelium (Terry RW et 
al., 1993). 
Garton et al. (Garton KJ et al., 2003) demonstrated in mice that VCAM-1 is 
released as a soluble form of the extracellular domain that is generated by 
TACE induced by phorbol 12-myristate 13-acetate (PMA). 
E-selectin is expressed in acute- as well as in a chronically-inflamed 
endothelium and induces rolling of circulating monocytes and/or leukocytes 
through this endothelium (Galkina E and Ley K, 2007; Shapiro NI et al., 
2010). 
ICAM-1 is also involved in atherosclerosis, presumably through the 
regulation of monocyte recruitment into atherosclerosis-prone areas. ICAM-
1 expression is elevated in aortas that are predisposed to atherosclerosis, 
and is regulated by pro-inflammatory stimuli such as that of TNF-α.  
E-selectin is involved in the leukocyte rolling on the endothelium, while 
VCAM-1 and ICAM-1 are involved in firm adhesion of leukocytes by binding 
to very late antigen (VLA-4) and to leukocyte function antigen (LFA-1), 
respectively. This mechanism is in accord with our findings in the functional 
experiments in which we observed no differences between leukocyte 
adhesion to activated HAEC in the presence or absence of AT.  
With respect to the proteins of each individual sCAM, we observe different 
degrees of response to the same stimuli (TNF-α 10 ng/mL) for each sCAM 
(13.31 ng/mL for sICAM-1, 7.71 ng/mL for sVCAM-1, and 0.33 ng/mL for 
sE-selectin); the contribution of each one being different in the adhesion 
step of atherosclerosis. Deneva-Koycheva et al. (Deneva-Koycheva TI et 
al., 2011) recently determined the reference ranges of sVCAM-1 (170.42 to 
478.36 ng/mL), sE-selectin ( 9.15 to 65.19 ng/mL) and sICAM-1 (128.9 to 
347.48 ng/mL) in serum of healthy Bulgarians, with no gender-related 
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differences in CAMs concentrations. Human CAMs serum concentrations 
are higher than those selected for the present study. 
BAY, at 1 µM and 0.1 µM in the present study, reduced sVCAM-1 protein 
release and VCAM-1 mRNA expression, respectively. BAY (1 µM) also 
reduced sE-selectin and sICAM-1 protein release as well as their mRNA 
expression, albeit the reduction was not statistically significant. At similar 
concentrations (2 µM or 5 µM or 12 µM) BAY has been described 
previously as inhibiting NF-κB in different cell types (Bage T et al., 2010; 
Juliana C et al., 2010; Calabro P et al., 2011). Accordingly, in our study, 
protein release of the studied sCAMs was reduced as well as the adhesion 
between activated HAEC and Jurkat-T-cells was reduced by BAY (0.5, 1, 2 
and 5 µM); statistical significance being reached at concentrations of BAY 
of 2 and 5 µM. 
Based on previous reports in HUVEC (Shaw DI et al., 2007; Tribolo S et 
al., 2008) and in HAEC (Szekanecz Z et al., 1994; Amberger A et al., 1997; 
Chen YH et al., 2001; Chen JW et al., 2003; Schleser S et al., 2006) in 
which the effects of compounds other than AT had been tested, we added 
TNF-α (at 10 ng/mL) to the HAEC culture for 24h to determine the sVCAM-
1 protein release. A mean of 74.74 pg/mL (range: 64 to 84) serum TNF-α 
concentration was recorded in healthy children (Lorini R et al., 1995) and, 
as reported by Tomiyama et al, control individuals have 1.7±0.5 pg/mL 
TNF-α in circulation while patients with obstructive sleep apnea have nearly 
2 pg/mL (Tomiyama H et al., 2008). Patients with systemic lupus 
erythematosus have 4.9±12.8 pg/mL and those with rheumatoid arthritis 
(an inflammatory disease) have 20±36.2 pg/mL (Bruni R et al., 2006; 
Vadacca M et al., 2008). Hence, under inflammatory conditions, serum 
TNF-α levels can be high, and approach the TNF-α levels used in this 
study. 
The production of adhesion molecules by endothelial cells has been shown 
to be regulated by redox-sensitive signal transduction and, thus, may be 
subjected to modulation by oxidants and antioxidants (Li H et al., 1993). 
Since AT is a potent antioxidant, it would be reasonable to assume that the 
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effects of this compound on reducing sVCAM-1 protein release in activated 
HAEC may be due, mainly, to its antioxidant properties in several 
endothelial cell types (Liu L et al., 2004). These outcomes are also 
observed at the mRNA expression level. Hence, the results demonstrate 
that, apart from its antioxidant activities, AT can exert a modest inhibitory 
effect on adhesion molecule expression in vitro, and this suggests an 
improvement in endothelial dysfunction in HAEC.  
It has been argued that HAEC or HUVEC may not adequately represent 
inflammatory changes in the microcirculation in tissues, since these cells 
are isolated from a large artery or vein, respectively. Microvascular cell line 
HMEC-1 is reportedly one of the endothelial cell lines most similar to 
primary endothelium (Liu L et al., 2004). Results of sVCAM-1 in HMEC-1 
cultures have shown wider variation than those from HUVEC experiments 
and it is mainly for this reason that HUVEC have been used extensively in 
in vitro endothelium studies (Videm V and Albrigtsen M, 2008). It is not 
clear, however, whether these differences render HMEC-1 a better, or a 
poorer, model of local inflammation than HUVEC. However, HUVEC 
provide more consistent results even if genetic differences between donors 
may result in wider variation in expression of inflammation markers (Videm 
V and Albrigtsen M, 2008). Further cell culture studies are required using 
HMEC-1 or human coronary artery endothelial cells to confirm the sVCAM-
1 results that had been observed in HAEC (Calabro P et al., 2011). 
 
Biomarkers of Food Intake and Metabolite Differences 
between Plasma and Red Blood Cell Matrices; a Human 
Metabolomic Profile Approach ( Study 3 ) 
Our data indicate that several specific molecular and nutritional biomarkers 
are associated with RBC, the measurement of which extend the data 
obtainable from their measurement in plasma alone in human studies. 
The biological samples from the ostensibly-healthy subjects in our study 
would be representative of a general population and, as such, optimal for 
standardizing the metabolomics procedures for future human studies 
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As an example of a robust metabolomic approach, the type of 
anticoagulant used for blood sample collection (sodium citrate or lithium 
heparin) was, in general, of note in evaluating parameters for measurement 
in plasma and RBC with the range of techniques currently at our disposal. 
Compared to lithium heparin plasma, there was an over-estimation in 
sodium citrate plasma of some aqueous metabolites found in human 
plasma and RBC, such us citrate. Since this type of blood-collection tube 
dilutes the sample i.e. the volume of sodium citrate (~ 250 µL of 0.129 M 
sodium citrate in a 2.7 mL blood sample collection tube) results in a “non 
real” or “inaccurate” measurement of the parameters-of-interest, we 
recommend using lithium heparin tubes (68 I.U.) for blood collection if 
plasma is the desired matrix for analyte measurement using NMR, GC-MS 
and UPLC-MS/MS. Other metabolomic studies support the use of lithium 
heparin anticoagulant for NMR-based metabolic profiling studies (Barton 
RH et al., 2010). 
As mentioned earlier, the volume of blood that can be accessed from the 
human individual for diagnostic and/or research purposes is limited. Also, 
most analytes are measured in plasma or serum, and the RBC are usually 
discarded. Our analyses have shown that plasma and RBC are different 
matrices which provide similar and complementary information. Depending 
on the parameter-of-interest, plasma and/or RBC matrices can be used 
independently. 
We observed that lipoprotein content was higher in plasma sample than in 
RBC and supports the classical concept that lipoproteins are transported in 
circulating plasma (Young SG, 1990). However, recent studies conducted 
by Bovenberg et al. suggested the presence of other pools of lipoproteins 
attached, possibly, to the endothelium or to other cells such as RBC 
(Verseyden C et al., 2004; Bovenberg SA et al., 2010; Bovenberg SA et al., 
2011). These postulations could open new applications for NMR analyses 
of RBC and their associated lipoprotein content in relation to several 
diseases such atherosclerosis and other lipid disorders where alternative 
blood-cell-mediated lipoprotein transport system has been proposed. For 
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example, the study by Bovenberg et al (Bovenberg SA et al., 2011) 
concluded that a high binding of RBC to apolipoprotein B could be 
protective against atherosclerosis.  
Our results showed that RBC are a particularly rich medium for the 
detection of SFA. These include palmitic acid (16:0), margaric acid (17:0), 
arachidic acid (20:0) and lignoceric acid (24:0), all of which are widely 
distributed in dairy products (such as butter, ghee, whole milk, cream, fatty 
cheeses), in fatty meats and animal fats (such as lard), in vegetable oils 
(such as palm oil, palm kernel and coconut oil) and fat-rich snacks 
(Diekman C et al., 2009). The PUFA that were identified included DHA 
(22:6 n-3) and arachidonic acid (20:4 n-6), and are common FA in 
vegetable oils (soybean oil, rapeseed oil, sunflower oil, olive oil) and in fatty 
fish, fish oil, nuts, seeds and products made from these e.g. soft 
margarines, mayonnaise and other derived products (Diekman C et al., 
2009). The concentrations of these FA were better detected in RBC than 
plasma, and could be used as a biomarker of the study participant’s 
consumption of specific food items over the previous weeks, or months 
(Sun Q et al., 2007).  
Compared to RBC, plasma was observed to have higher content of SFA 
such as myristic acid (14:0), or MUFA such as myristoleic acid (14:1 n-5), 
palmitoleic acid (16:1 n-7), 17:1 n-7 and oleic acid (18:1 n-9) as well as of 
PUFA such as alpha-linoleic acid (18:3 n-3), linoleic acid (18:2 n-6), 
gamma-linolenic acid (18:3 n-6) and 20:3 n-6. 
We observed that the quantities of FA (expressed as µg/mL) in plasma and 
RBC better describe the data obtained, while FA percentages makes 
comparisons between specimens easier. These raw data will be accessible 
for the next generation of metabolomic software and bioinformatics analysis 
tools. However, such tools can only be developed and optimized if there 
are standardized methodologies (Griffin JL and Steinbeck C, 2010) such as 
we have proposed. 
In dietary studies in general, 3- to 7-day food records are considered to be 
the most accurate means of intake assessment. However, such methods 
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are not feasible in large cohort studies (Siri-Tarino PW et al., 2010). 
Metabolic profiles, as our study proposes, would more accurately reflect 
short- medium- and long-term dietary intakes and, as such, would be more 
effective in evaluating, for example, the health benefit claims of 
manufactured functional food products. 
RBC better reflect long-term dietary FA intake than plasma, as has been 
previously suggested. Since the biological half-life of RBC is of the order of 
55 days, the measurements in RBC would reflect the mean FA status of the 
previous 3 months. Depending on the FA of interest and the study 
objectives, plasma and/or RBC should be analyzed so as to provide 
complementary information. For example, it has been suggested that, in 
epidemiology/nutrition studies, FA composition measured in RBC is a 
viable alternative to adipose tissue biopsy for determining long-term FA 
consumption. 
In our study, polyphenols associated with RBC were detected in the fasting 
state, and were different from those measured in the corresponding 
plasma. Thus, there is the promising option that RBCs may provide a 
longer-term measure of polyphenolic intake in nutrition studies. However, 
we were unable to identify several peaks from the UPLC-LC-MS spectra; 
more detailed and accurate techniques for the identification of these 
metabolites are needed, and the information added to the current 
databases  
The ultimate goals of these ‘omics’ studies are to identify the molecular 
signatures of dietary nutrients, and non-nutrients, that could result in a 
specific “desirable” phenotype and, hence, to provide personalized 
nutritional recommendations for health maintenance as well as for disease 
prevention 
There are two main limitations of our study. The first limitation is the small 
number of subjects studied. Our results are preliminary and focus mainly 
on the gross effects of blood sample collection and the possible effects on 
the metabolomic approach to a nutritional study. The second limitation is 
the lack of a database containing the assignments and identification of 
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several polyphenol peaks in the spectra derived from plasma and RBC, as 
assessed by UPLC-MS/MS. Future studies would require more accurate 
techniques for polyphenol detection and identification. 
These drawbacks limit the conclusions that could be drawn. However, the 
positive benefit of our study is the detailed insight into measurements 
conducted in plasma and RBC matrices from different methods of blood 
anticoagulation. Our results indicate that lithium heparin anticoagulant is to 
be preferred. We have applied the combination of NMR spectroscopy, GC-
MS and UPLC-MS/MS approaches in combination in order to generate 
metabolomic profiles in our human volunteers. Thus, RBC versus plasma 
measurements provide complementary metabolic information with respect 
to several specific molecular biomarkers which could be applied in 
nutritional assessments. 
 
Overall discussion  
The present work provides a cellular model to study the activity of food 
extracts and/or bioactive compounds that have the potential to promote 
beneficial affects on the levels of molecular biomarkers of atherosclerosis 
including cytokines (TNF-α) and CAMs (VCAM-1, E-selectin and ICAM-1). 
One line of investigation involved the mechanisms-of-action of a popular 
food item (peanut extract) which has high polyphenol content. We used the 
atherosclerosis-specific biological system, THP-1 monocytes; an 
established model for studying inflammation. We observed that polyphenol-
rich peanut extract acts at the nuclear level by inhibiting c-Jun transcription 
factor, thereby preventing TNF-α production. Another line of investigation 
involved the atherosclerosis-specific biological cell approach i.e. HAECs 
which are associated with endothelial function. We observed that AT and 
BAY, natural and synthetic molecules respectively, reduced CAMs in 
HAECs and improved endothelial function. Our results confirmed the 
proposal that the atherosclerosis-specific biological cell approach (i.e. THP-
1 and HAECs), is effective in evaluating the molecular mechanisms-of-
action of food extracts and/or bioactive compounds. 
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A pre-incubation with natural food extracts and/or bioactive compounds 
may prevent, in the cellular models studied, inflammation and endothelial 
dysfunction. This pre-incubation is necessary to observe any protective 
effects against inflammation and endothelial dysfunction stimuli accruing 
from dietary and other lifestyle habits. These in vitro results provide the 
bases for future dietary recommendations such as the inclusion of foods 
with high content of certain bioactive compounds, including phytosterols 
(Sanclemente T et al., 2009), to decrease the risk of atherosclerosis. 
However, the expected benefits in health are not usually achieved by the 
consumption of a single food item, called “functional food”. Foods are 
regarded as “functional” when it can be satisfactorily demonstrated that 
they beneficially affect one or more target functions in the body, beyond the 
known nutritional effects. This “functional” effect is towards an improved 
health state and well-being and/or reduction of disease risk (Contor L, 
2001). Functional foods should be consumed within the framework of 
healthy-eating habits with an adequate and balanced distribution of 
nutrients to induce benefits in health. The present work used two 
repeatable and reproducible cellular models, which “simulate” different 
stages of atherosclerosis lesions. These two models could be used to study 
changes in disease biomarkers at the molecular level and test different 
natural and synthetic molecules. Further, these cellular models could 
contribute to the study of mechanisms-of-action of natural extracts or 
compounds. Although, studies using the atherosclerosis-specific biological 
cell approach are effective in investigating food extracts and/or 
mechanisms-of-action of bioactive compounds, human studies are always 
necessary for a better, and more realistic, understanding of the health 
benefits and of disease recognition/prevention. 
Whole blood can offer considerable, and different, information on the 
individual’s health status. Optimization of sample isolation and of the 
analytical techniques is required to obtain maximum information from each 
component of blood such as plasma and RBC, or serum. 
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To further achieve our profiling objectives, it was necessary to develop an 
accurate methodology to qualitatively and quantitatively detect, and 
characterize, the metabolized food compounds such as FA and 
polyphenols. Hence, we used highly sensitive techniques such as NMR, 
GC-MS and UPLC-MS/MS to identify specific metabolites in human 
biological samples. Specifically, we studied two matrices (human plasma 
and RBC) which can offer us complementary metabolomic profile 
information when assessed with these powerful techniques. Despite the 
power of these techniques to detect various constituents of the biological 
samples, the main problem remains data analysis and processing. In future 
studies, the key aspect for accurate and detailed characterization of 
specific metabolites is the availability of accurate databases. The vast 
volume of data generated in metabolomics has created the need for 
comprehensive, well-annotated, and user-friendly databases. These 
databases should be able to store and manage the disparate and complex 
data, with appropriate annotations and descriptors. Only then would 
metabolomics be able to meet the challenges posed by the generation of 
the enormous information cascade (Go EP, 2010). The implementation of 
data standardization will assist metabolomics to strengthen its integration 
with genomics, transcriptomics, and proteomics, thus providing an 
integrated view of biological systems (Go EP, 2010). Specific and precise 
techniques are required for a better assignment and identification of 
polyphenols when comparisons are made with existing databases. 
Considerable data have been assembled on the biological activity of food 
extracts and/or bioactive compounds using the atherosclerosis-specific 
biological cell approach. Also, the analyses of metabolites in human 
plasma and RBC have highlighted the usefulness of certain metabolites as 
biomarkers of food intake. However, one further step is required. This 
involves the synthesis and isolation of the specific nutritional biomarkers-of-
interest and the evaluation of their mechanisms-of-action using the 
atherosclerosis-specific biological cell approach. This concept is graphically 
represented in Figure 45 . 
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Figure  45. Proposed stragegies for the evaluation of nutritional effets on human health.  
  
Further, it would be of considerable interest to characterize food intake 
biomarkers detected in plasma and RBC, and to relate them to a specific 
food-item intake. Tools such as 24 hR and FFQ would be necessary to 
quantify specific food intakes in humans, followed by a comparison of FA 
and polyphenol data obtained from metabolic profile analysis of plasma and 
RBC. 
As such, present and future goals would be to investigate the short- and 
medium-term effects of diets with respect to disease prevention via the 
identification and monitoring of new nutritional biomarkers of food intake 
































•Synthesis and isolation of metabolites
•Study of their mechanism of action
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1. The models, of inflammation using THP-1 monocytes and of endothelial 
dysfunction using HAEC, are effective as biological-cell approaches in the 
investigation of atherosclerosis. The methods are repeatable and 
reproducible in testing the potential beneficial effects of natural and 
manufactured extracts, and/or compounds. 
 
2.   A pre-incubation with polyphenol-rich peanut extract and AT, in the 
cellular models studied, is necessary in order to observe protective effects 
against inflammation and endothelial dysfunction stimuli. 
 
3.   Polyphenol-rich peanut extract exerts an anti-inflammatory effect by 
reducing extracellular TNF-α protein concentration. This peanut extract 
mechanism-of-action is via the inhibition of c-Jun transcription factor 
activity. AT improves endothelial function specifically by inhibiting VCAM-1 
at the mRNA and the protein levels. 
 
4.   BAY is confirmed as an effective control molecule for the cell models 
under study. BAY can reduce TNF-α protein (total, extra- and intracellular) 
and TNF-α mRNA levels by inhibiting c-Jun, MEF2 and NF-κB transcription 
factor activity and TACE activity in THP-1 cells. BAY can also reduce 
sVCAM-1, sE-selectin and sICAM-1 protein as well as their mRNA levels 
and, in the endothelial dysfunction model, the adhesion between activated 
HAECs and Jurkat-T-cells. 
 
5.    The combination of NMR spectroscopy, GC-MS and UPLC-MS/MS 
techniques are efficient in generating metabolomic profiles of several 
specific biomarkers of food intake and metabolites (FA, polyphenol, 
aqueous metabolites and lipoprotein content) in plasma and RBC of human 
subjects. 
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6.  Plasma and RBC are two matrices that add complementary information 
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1. Contributions at Congresses and Conferences  
1.1 Posters  
Fernández-Castillejo S, Catalán Ú , Pons L, Heras M, Masana L and Sola 
R. Desarrollo metodológico de un modelo celular in vitro para el 
estudio de los efectos anticoagulantes de extractos o compuestos 
bioactivos naturales . XXII Congreso nacional de la sociedad española de 
arteriosclerosis. Pamplona, 27-29 May 2009 
 
Pons L, Fernández-Castillejo S, Catalán Ú , Heras M, Girona J, Masana L 
and Solà R. Desarrollo metodológico de un modelo celular in vitro 
para el estudio de los efectos en la expresión génica de la endothelial 
nitric oxide synthase de compuestos bioactivos naturales y de la 
insulina.  XXII Congreso nacional de la sociedad española de 
arteriosclerosis. Pamplona, 27-29 May 2009 
 
Romeu M, Valls RM, Albaladejo R, Sánchez-Martos V, Catalán Ú , 
Fernández-Castillejo S, Aranda N, Espinel A, Delgado MA, Arija V, Giralt M 
and Solà R. Marcadores de estrés oxidativo relacionados con las 
enfermedades cardiovasculares en humanos sanos . XXII Congreso 
nacional de la sociedad española de arteriosclerosis. Pamplona, 27-29 
May 2009 
 
Catalán Ú , Fernández-Castillejo S, Pons L, Heras M, Anglès N and Solà R. 
Alfa-tocoferol y BAY mejoran la disfunción endotelial reduciendo la 
VCAM-1: un modelo celular para estudiar compuestos bioactivos.  
XXIII Congreso nacional de la sociedad española de arteriosclerosis. 
Córdoba, 09-11 June 2010 “special research mention” 
 
Fernández-Castillejo S, Catalán Ú , Pons L and Solà R. Reduction of 
Tissue Factor Activity, Protein and mRNA Expression in Response to 
Polyphenols in Human Aortic Endothelial Cells Exposed to 
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Pathophysiological Stimuli as Tumor Necrosis Factor-alpha.  4th 
Congress of the International Society of Nutrigenetics/Nutrigenomics 
(ISNN). Pamplona, 18-20 November 2010 
 
Catalán Ú , Pons L, Fernández-Castillejo S, Heras M, Anglès N, Morello JR 
and Solà R. Bioactive Compounds Improve Endothelial Dysfunction by 
Reducing VCAM-1 mRNA Expression and Its Soluble Protein Form in 
Human Aortic Endothelial Cells. 4th Congress of the International Society 
of Nutrigenetics/Nutrigenomics (ISNN). Pamplona, 18-20 November 2010 
 
Catalán Ú , Fernández-Castillejo S, Rodríguez MA, Vinaixa M, Ras MR, 
Martorell I, Correig X and Solà R. Comparación del perfil metabolómico 
de dos matrices biológicas: plasma y eritrocitos humanos.  XXIV 
Congreso nacional de la sociedad española de arteriosclerosis. Sevilla, 25-
27 May 2011 
 
Pedret A, Valls RM, Fernández-Castillejo S, Catalán Ú , Romeu M, 
Lamuela-Raventós RM, Arija V and Solà R. Fermented alcoholic 
beverages, urinary total polyphenol excretion and DNA oxidative 
damage biomarker in healthy subjects.  XXIV Congreso nacional de la 
sociedad española de arteriosclerosis. Sevilla, 25-27 May 2011 
 
Catalán Ú , Macià A, Fernández-Castillejo S, Martorell I, Valls RM, Pedret 
A, Giralt M, Motilva MJ and Solà R. Is the polyphenolic profile in 
erythrocytes a nutricional biomarker?. 5th International Conference on 
Polyphenols and Health. Sitges, 17-20 October 2011 
 
Pedret A, Valls RM, Fernández-Castillejo S, Catalán Ú , Romeu M, Giralt 
M, Lamuela-Raventós RM, Medina-Remón A, Arija V, Aranda N, Espinel A 
and Solà R. Polyphenol-rich foods Project against oxidative damage in 
healthy subjects.  5th International Conference on Polyphenols and 
Health. Sitges, 17-20 October 2011 
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Catalán Ú , Rodríguez MA, Ras MR, Macià A, Mallol R, Vinaixa M, 
Fernández-Castillejo S, Valls RM, Pedret A, Griffin JL, Salek R, Correig X, 
Motilva MJ and Solà R. Biomarkers of Food intake and Metabolite 
Differences between Plasma and Red Blood Cell Matrices; a Human 
Metabolomic profile approach. XXV Congreso nacional de la sociedad 
española de arteriosclerosis. Reus, 06-08 June 2012 
 
Pedret A, Valls RM, Fernández-Castillejo S, Catalán Ú , Lamuela-Raventós 
RM, Medina-Remón A, Espinel A and Solà R. Polyphenol-rich foods 
exhibit DNA anti-oxidative properties and protect the glutathione 
system in healthy subjects. XXV Congreso nacional de la sociedad 
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1.2 Oral communications  
Fernández-Castillejo S, Catalán Ú , Pons L and Solà R. El resveratrol 
reduce la actividad, la expresión génica y la proteica del factor tisular 
en células endoteliales de aorta humana. XXIII Congreso nacional de la 
sociedad española de arteriosclerosis. Córdoba, 09-11 June 2010 
 
Fernández-Castillejo S, Farràs M, Catalán Ú , Pedret A, Konstantinidou V, 
Muñoz-Aguayo D, Solà R and Fitó M. Efecto del consumo del aceite de 
oliva y sus compuestos fenólicos sobre la fluidez de la HDL. XXV 
Congreso nacional de la sociedad española de arteriosclerosis. Reus, 06-
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2. Scientific papers  
Solà-Alberich R, Valls-Zamora RM, Fernández-
Castillejo S, Catalán-Santos Ú , Pedret-Figuerola A, 
Giralt-Batista M and Konstantinidou V. Do phenolic 
compounds exercise their effects by new pathways 
or mechanisms that would explain the healthy heart 
effects of virgin olive oil?.  Clin Invest Arterioscl. 
2011;23(6):275-277 
 
Pedret A, Valls RM, Fernández-Castillejo S, Catalán 
Ú,  Romeu M, Giralt M, Lamuela-Raventós RM, 
Medina-Ramón A, Arija V, Aranda N, Espinel A and 
Solà R. Polyphenol-rich foods protect against 
oxidative damage in healthy subjects. (accepted for 
publication in the Molecular Nutrition and Food 
Research; DOI: 10.1002/mnfr.2011.00.676 ) 
 
Catalán Ú , Fernández-Castillejo S, Pons L, Heras M, 
Aragonés G, Anglès N, Morello JR and Solà R. Alpha-
tocopherol and BAY 11-7082 Reduce Vascular Cell 
Adhesion Molecule in Human Aortic Endothelial 
Cells.  J Vasc Res. 2012;49(4):319-328 
 
Catalán Ú , Fernández-Castillejo S, Anglès N, Morello 
JR, Yebras M and Sola R. Inhibition of the 
transcription factor c-Jun by the MAPK family, and 
not the NF- κB pathway, suggests that peanut 
extract has anti-inflammatory properties. Mol 
Immunol. 2012;52(3-4):125-132 
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Catalán Ú , Rodríguez MA, Ras MR, Macià A, Mallol R, Vinaixa M, 
Fernández-Castillejo S, Valls RM, Pedret A, Griffin JL, Salek R, Correig X, 
Motilva MJ and Solà R. Biomarkers of Food intake and Metabolite 
Differences between Plasma and Red Blood Cell Matrices; a Human 
Metabolomic profile approach. (editor submitted) 
 
Catalán Ú , Fernández-Castillejo S, Pons L and Solà R. Resveratrol 
reduces tissue factor activity, its mRNA levels and protein expression 
in human aortic endothelial cells: Possible beneficial effects from 
dietary supplementation. (editor submitted) 
 
Fernández-Castillejo S, Pons L, Catalán Ú , Heras M, González C, Rosales 
R, Girona J, Masana L, Anglès N, Morello JR and Solà R. 
Lipopolysaccharide-induced tumor necrosis alpha secretion in 
monocytes thp-1: methodological aspects to reduce assay variability. 
(editor submitted) 
 
Fernández-Castillejo S, Pons L, Catalán Ú , Girona J, Rosales R, Anglès N, 
Morello JR and Solà R. An in vitro assay to test endothelial function: 
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3. Other contributions  
3.1 Book chapter  
Los perfiles nutricionales de los alimentos y la obesidad en Europa. [Food’s 
Nutrition Profiles and Obesity in Europe]  
Solà R, Valls RM, Albaladejo RM, Fernàndez-Castillejo S, Pons L, Catalan 
Ú, Romeu M and Giralt M. in La frontera / convergencia entre medicina y 
salud. [The Converging Frontier between Medicine and Health] Valladolid: 
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4. Visits to other international centres  
4.1 Erasmus Intensive Programme  
Combating Obesity: Strategies for Prevention and Intervention “COSPI 3” 
Grundlsee, February 22nd – March 8th, 2009  
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4.2 European Visit  
Visit to the Department of Biochemistry learning metabolomics. Cambridge, 
United Kingdom. June 21st – September 17th, 2010. 
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